NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1780598599|emb|VYS53513|]
View 

unnamed protein product [Arabidopsis thaliana]

Protein Classification

leucine-rich repeat domain-containing protein; leucine-rich repeat protein kinase family protein( domain architecture ID 11476383)

leucine-rich repeat (LRR) domain-containing protein may participate in protein-protein interactions; protein kinase family protein containing leucine-rich repeat(s), may catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine and/or tyrosine residues on protein substrates; similar to plant LRR receptor-like kinases

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PLN00113 PLN00113
leucine-rich repeat receptor-like protein kinase; Provisional
12-960 0e+00

leucine-rich repeat receptor-like protein kinase; Provisional


:

Pssm-ID: 215061 [Multi-domain]  Cd Length: 968  Bit Score: 1631.48  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  12 YLITTLFFLFLNFSCLHANELELLLSFKSSIQDPLKHLSSWSysSTNDVCLWSGVVCNNISRVVSLDLSGKNMSGQIlTA 91
Cdd:PLN00113   11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWN--SSADVCLWQGITCNNSSRVVSIDLSGKNISGKI-SS 87
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  92 ATFRLPFLQTINLSNNNLSGPIPHDIFTTSSpSLRYLNLSNNNFSGSIPRGFLPNLYTLDLSNNMFTGEIYNDIGVFSNL 171
Cdd:PLN00113   88 AIFRLPYIQTINLSNNQLSGPIPDDIFTTSS-SLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSL 166
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 172 RVLDLGGNVLTGHVPGYLGNLSRLEFLTLASNQLTGGVPVELGKMKNLKWIYLGYNNLSGEIPYQIGGLSSLNHLDLVYN 251
Cdd:PLN00113  167 KVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 252 NLSGPIPPSLGDLKKLEYMFLYQNKLSGQIPPSIFSLQNLISLDFSDNSLSGEIPELVAQMQSLEILHLFSNNLTGKIPE 331
Cdd:PLN00113  247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 332 GVTSLPRLKVLQLWSNRFSGGIPANLGKHNNLTVLDLSTNNLTGKLPDTLCDSGHLTKLILFSNSLDSQIPPSLGMCQSL 411
Cdd:PLN00113  327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSL 406
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 412 ERVRLQNNGFSGKLPRGFTKLQLVNFLDLSNNNLQGNINT--WDMPQLEMLDLSVNKFFGELPDFSRSKRLKKLDLSRNK 489
Cdd:PLN00113  407 RRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSrkWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQ 486
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 490 ISGVVPQGLMTFPEIMDLDLSENEITGVIPRELSSCKNLVNLDLSHNNFTGEIPSSFAEFQVLSDLDLSCNQLSGEIPKN 569
Cdd:PLN00113  487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKN 566
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 570 LGNIESLVQVNISHNLLHGSLPFTGAFLAINATAVEGNIDLCSENSASGLRPCKVVRKrsTKSWWLIITSTFAAFLAVLV 649
Cdd:PLN00113  567 LGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK--TPSWWFYITCTLGAFLVLAL 644
                         650       660       670       680       690       700       710       720
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 650 SGFfiVLVFQRTHNVLEVKKVEQEDGTkWETQFFDSKFMKSFTVNTILSSLKDQNVLVD------------KNGVHFVVK 717
Cdd:PLN00113  645 VAF--GFVFIRGRNNLELKRVENEDGT-WELQFFDSKVSKSITINDILSSLKEENVISRgkkgasykgksiKNGMQFVVK 721
                         730       740       750       760       770       780       790       800
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 718 EVKKYDSLPEM-ISDMRKLsDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSGLSWERRRKIMKGIVEALRFLHCRC 796
Cdd:PLN00113  722 EINDVNSIPSSeIADMGKL-QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRC 800
                         810       820       830       840       850       860       870       880
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 797 SPAVVAGNLSPENIVIDVTDEPRLCLGLPGLLCMD------AAYMAPETREHKEMTSKSDIYGFGILLLHLLTGKCSSsn 870
Cdd:PLN00113  801 SPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDtkcfisSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA-- 878
                         890       900       910       920       930       940       950       960
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 871 eDIESGVNGSLVKWARYSYSNCHIDTWIDSSI--DTSVHQREIVHVMNLALKCTAIDPQERPCTNNVLQALESTSSSSSS 948
Cdd:PLN00113  879 -DAEFGVHGSIVEWARYCYSDCHLDMWIDPSIrgDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957
                         970
                  ....*....|..
gi 1780598599 949 CTTYLsKILSLA 960
Cdd:PLN00113  958 CVTGL-KFSSLF 968
 
Name Accession Description Interval E-value
PLN00113 PLN00113
leucine-rich repeat receptor-like protein kinase; Provisional
12-960 0e+00

leucine-rich repeat receptor-like protein kinase; Provisional


Pssm-ID: 215061 [Multi-domain]  Cd Length: 968  Bit Score: 1631.48  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  12 YLITTLFFLFLNFSCLHANELELLLSFKSSIQDPLKHLSSWSysSTNDVCLWSGVVCNNISRVVSLDLSGKNMSGQIlTA 91
Cdd:PLN00113   11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWN--SSADVCLWQGITCNNSSRVVSIDLSGKNISGKI-SS 87
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  92 ATFRLPFLQTINLSNNNLSGPIPHDIFTTSSpSLRYLNLSNNNFSGSIPRGFLPNLYTLDLSNNMFTGEIYNDIGVFSNL 171
Cdd:PLN00113   88 AIFRLPYIQTINLSNNQLSGPIPDDIFTTSS-SLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSL 166
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 172 RVLDLGGNVLTGHVPGYLGNLSRLEFLTLASNQLTGGVPVELGKMKNLKWIYLGYNNLSGEIPYQIGGLSSLNHLDLVYN 251
Cdd:PLN00113  167 KVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 252 NLSGPIPPSLGDLKKLEYMFLYQNKLSGQIPPSIFSLQNLISLDFSDNSLSGEIPELVAQMQSLEILHLFSNNLTGKIPE 331
Cdd:PLN00113  247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 332 GVTSLPRLKVLQLWSNRFSGGIPANLGKHNNLTVLDLSTNNLTGKLPDTLCDSGHLTKLILFSNSLDSQIPPSLGMCQSL 411
Cdd:PLN00113  327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSL 406
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 412 ERVRLQNNGFSGKLPRGFTKLQLVNFLDLSNNNLQGNINT--WDMPQLEMLDLSVNKFFGELPDFSRSKRLKKLDLSRNK 489
Cdd:PLN00113  407 RRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSrkWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQ 486
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 490 ISGVVPQGLMTFPEIMDLDLSENEITGVIPRELSSCKNLVNLDLSHNNFTGEIPSSFAEFQVLSDLDLSCNQLSGEIPKN 569
Cdd:PLN00113  487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKN 566
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 570 LGNIESLVQVNISHNLLHGSLPFTGAFLAINATAVEGNIDLCSENSASGLRPCKVVRKrsTKSWWLIITSTFAAFLAVLV 649
Cdd:PLN00113  567 LGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK--TPSWWFYITCTLGAFLVLAL 644
                         650       660       670       680       690       700       710       720
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 650 SGFfiVLVFQRTHNVLEVKKVEQEDGTkWETQFFDSKFMKSFTVNTILSSLKDQNVLVD------------KNGVHFVVK 717
Cdd:PLN00113  645 VAF--GFVFIRGRNNLELKRVENEDGT-WELQFFDSKVSKSITINDILSSLKEENVISRgkkgasykgksiKNGMQFVVK 721
                         730       740       750       760       770       780       790       800
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 718 EVKKYDSLPEM-ISDMRKLsDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSGLSWERRRKIMKGIVEALRFLHCRC 796
Cdd:PLN00113  722 EINDVNSIPSSeIADMGKL-QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRC 800
                         810       820       830       840       850       860       870       880
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 797 SPAVVAGNLSPENIVIDVTDEPRLCLGLPGLLCMD------AAYMAPETREHKEMTSKSDIYGFGILLLHLLTGKCSSsn 870
Cdd:PLN00113  801 SPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDtkcfisSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA-- 878
                         890       900       910       920       930       940       950       960
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 871 eDIESGVNGSLVKWARYSYSNCHIDTWIDSSI--DTSVHQREIVHVMNLALKCTAIDPQERPCTNNVLQALESTSSSSSS 948
Cdd:PLN00113  879 -DAEFGVHGSIVEWARYCYSDCHLDMWIDPSIrgDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957
                         970
                  ....*....|..
gi 1780598599 949 CTTYLsKILSLA 960
Cdd:PLN00113  958 CVTGL-KFSSLF 968
LRR COG4886
Leucine-rich repeat (LRR) protein [Transcription];
26-401 1.15e-33

Leucine-rich repeat (LRR) protein [Transcription];


Pssm-ID: 443914 [Multi-domain]  Cd Length: 414  Bit Score: 134.68  E-value: 1.15e-33
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  26 CLHANELELLLSFKSSIQDPLKHLSSWSYSSTNDVCLWSGVVCNNISRVVSLDLSGKNMSGQILTAATFRLPFLQTINLS 105
Cdd:COG4886     1 LLLLLLSLTLKLLLLLLLELLTTLILLLLLLLLLLALLLLSLLSLLLLLTLLLSLLLRDLLLSSLLLLLSLLLLLLLSLL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 106 NNNLSGPIPHDIftTSSPSLRYLNLSNNNFSGSiprgfLPNLYTLDLSNNMFTgEIYNDIGVFSNLRVLDLGGNVLTgHV 185
Cdd:COG4886    81 LLSLLLLGLTDL--GDLTNLTELDLSGNEELSN-----LTNLESLDLSGNQLT-DLPEELANLTNLKELDLSNNQLT-DL 151
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 186 PGYLGNLSRLEFLTLASNQLTGgVPVELGKMKNLKWIYLGYNNLSgEIPYQIGGLSSLNHLDLVYNNLSgPIPPSLGDLK 265
Cdd:COG4886   152 PEPLGNLTNLKSLDLSNNQLTD-LPEELGNLTNLKELDLSNNQIT-DLPEPLGNLTNLEELDLSGNQLT-DLPEPLANLT 228
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 266 KLEYMFLYQNKLSGqiPPSIFSLQNLISLDFSDNSLSgEIPELvAQMQSLEILHLFSNNLTGKIPEGVTSLPRLKVLQLW 345
Cdd:COG4886   229 NLETLDLSNNQLTD--LPELGNLTNLEELDLSNNQLT-DLPPL-ANLTNLKTLDLSNNQLTDLKLKELELLLGLNSLLLL 304
                         330       340       350       360       370
                  ....*....|....*....|....*....|....*....|....*....|....*.
gi 1780598599 346 SNRFSGGIPANLGKHNNLTVLDLSTNNLTGKLPDTLCDSGHLTKLILFSNSLDSQI 401
Cdd:COG4886   305 LLLLNLLELLILLLLLTTLLLLLLLLKGLLVTLTTLALSLSLLALLTLLLLLNLLS 360
STKc_IRAK cd14066
Catalytic domain of the Serine/Threonine kinases, Interleukin-1 Receptor Associated Kinases ...
709-940 7.28e-33

Catalytic domain of the Serine/Threonine kinases, Interleukin-1 Receptor Associated Kinases and related STKs; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. IRAKs are involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) signalling pathways, and are thus critical in regulating innate immune responses and inflammation. Some IRAKs may also play roles in T- and B-cell signaling, and adaptive immunity. Vertebrates contain four IRAKs (IRAK-1, -2, -3 (or -M), and -4) that display distinct functions and patterns of expression and subcellular distribution, and can differentially mediate TLR signaling. IRAK-1, -2, and -4 are ubiquitously expressed and are active kinases, while IRAK-M is only induced in monocytes and macrophages and is an inactive kinase. Variations in IRAK genes are linked to diverse diseases including infection, sepsis, cancer, and autoimmune diseases. IRAKs contain an N-terminal Death domain (DD), a proST region (rich in serines, prolines, and threonines), a central kinase domain (a pseudokinase domain in the case of IRAK3), and a C-terminal domain; IRAK-4 lacks the C-terminal domain. This subfamily includes plant receptor-like kinases (RLKs) including Arabidopsis thaliana BAK1 and CLAVATA1 (CLV1). BAK1 functions in BR (brassinosteroid)-regulated plant development and in pathways involved in plant resistance to pathogen infection and herbivore attack. CLV1, directly binds small signaling peptides, CLAVATA3 (CLV3) and CLAVATA3/EMBRYO SURROUNDING REGI0N (CLE), to restrict stem cell proliferation: the CLV3-CLV1-WUS (WUSCHEL) module influences stem cell maintenance in the shoot apical meristem, and the CLE40 (CLAVATA3/EMBRYO SURROUNDING REGION40) -ACR4 (CRINKLY4) -CLV1- WOX5 (WUSCHEL-RELATED HOMEOBOX5) module at the root apical meristem. The IRAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270968 [Multi-domain]  Cd Length: 272  Bit Score: 128.54  E-value: 7.28e-33
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 709 KNGVHFVVK---------EVKKYDSLPEMISDMRklsdHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG------L 773
Cdd:cd14066    15 ENGTVVAVKrlnemncaaSKKEFLTELEMLGRLR----HPNLVRLLGYCLESDEKLLVYEYMPNGSLEDRLHChkgsppL 90
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 774 SWERRRKIMKGIVEALRFLHCRCSPAVVAGNLSPENIVID------VTD-------EPRLCLGLPGLLCMDAAYMAPETR 840
Cdd:cd14066    91 PWPQRLKIAKGIARGLEYLHEECPPPIIHGDIKSSNILLDedfepkLTDfglarliPPSESVSKTSAVKGTIGYLAPEYI 170
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 841 EHKEMTSKSDIYGFGILLLHLLTGKCSSSNEDIESGVNgSLVKWARYSYSNC---HIDTWIDSsiDTSVHQREIVHVMNL 917
Cdd:cd14066   171 RTGRVSTKSDVYSFGVVLLELLTGKPAVDENRENASRK-DLVEWVESKGKEEledILDKRLVD--DDGVEEEEVEALLRL 247
                         250       260
                  ....*....|....*....|...
gi 1780598599 918 ALKCTAIDPQERPCTNNVLQALE 940
Cdd:cd14066   248 ALLCTRSDPSLRPSMKEVVQMLE 270
Pkinase pfam00069
Protein kinase domain;
709-930 5.25e-13

Protein kinase domain;


Pssm-ID: 459660 [Multi-domain]  Cd Length: 217  Bit Score: 69.19  E-value: 5.25e-13
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 709 KNGVHFVVKEVKKYDSLPEM-------ISDMRKLSdHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLS---GLSWERR 778
Cdd:pfam00069  22 DTGKIVAIKKIKKEKIKKKKdknilreIKILKKLN-HPNIVRLYDAFEDKDNLYLVLEYVEGGSLFDLLSekgAFSEREA 100
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 779 RKIMKGIVEALRFLHCRCSPAVvagnlSPEnividvtdeprlclglpgllcmdaaYMAPETREHKEMTSKSDIYGFGILL 858
Cdd:pfam00069 101 KFIMKQILEGLESGSSLTTFVG-----TPW-------------------------YMAPEVLGGNPYGPKVDVWSLGCIL 150
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1780598599 859 LHLLTGK----CSSSNEDIESGVNGSLvkwarysYSNCHIDTWIDSSIDtsvhqreivhvmnLALKCTAIDPQERP 930
Cdd:pfam00069 151 YELLTGKppfpGINGNEIYELIIDQPY-------AFPELPSNLSEEAKD-------------LLKKLLKKDPSKRL 206
S_TKc smart00220
Serine/Threonine protein kinases, catalytic domain; Phosphotransferases. Serine or ...
709-937 1.60e-11

Serine/Threonine protein kinases, catalytic domain; Phosphotransferases. Serine or threonine-specific kinase subfamily.


Pssm-ID: 214567 [Multi-domain]  Cd Length: 254  Bit Score: 65.63  E-value: 1.60e-11
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  709 KNGVHFVVKEVKK--YDSLPEM----ISDMRKLsDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLS---GLSWERRR 779
Cdd:smart00220  22 KTGKLVAIKVIKKkkIKKDRERilreIKILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKkrgRLSEDEAR 100
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  780 KIMKGIVEALRFLHCRCspaVVAGNLSPENIVIDVTDEP--------RLCLGLPGLLCMD--AAYMAPETREHKEMTSKS 849
Cdd:smart00220 101 FYLRQILSALEYLHSKG---IVHRDLKPENILLDEDGHVkladfglaRQLDPGEKLTTFVgtPEYMAPEVLLGKGYGKAV 177
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  850 DIYGFGILLLHLLTGK--CSSSNEDIEsgvngsLVKWARYSYSNCHIDTWIDSSidtsvhqreivHVMNLALKCTAIDPQ 927
Cdd:smart00220 178 DIWSLGVILYELLTGKppFPGDDQLLE------LFKKIGKPKPPFPPPEWDISP-----------EAKDLIRKLLVKDPE 240
                          250
                   ....*....|
gi 1780598599  928 ERPCTNNVLQ 937
Cdd:smart00220 241 KRLTAEEALQ 250
 
Name Accession Description Interval E-value
PLN00113 PLN00113
leucine-rich repeat receptor-like protein kinase; Provisional
12-960 0e+00

leucine-rich repeat receptor-like protein kinase; Provisional


Pssm-ID: 215061 [Multi-domain]  Cd Length: 968  Bit Score: 1631.48  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  12 YLITTLFFLFLNFSCLHANELELLLSFKSSIQDPLKHLSSWSysSTNDVCLWSGVVCNNISRVVSLDLSGKNMSGQIlTA 91
Cdd:PLN00113   11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWN--SSADVCLWQGITCNNSSRVVSIDLSGKNISGKI-SS 87
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  92 ATFRLPFLQTINLSNNNLSGPIPHDIFTTSSpSLRYLNLSNNNFSGSIPRGFLPNLYTLDLSNNMFTGEIYNDIGVFSNL 171
Cdd:PLN00113   88 AIFRLPYIQTINLSNNQLSGPIPDDIFTTSS-SLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSL 166
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 172 RVLDLGGNVLTGHVPGYLGNLSRLEFLTLASNQLTGGVPVELGKMKNLKWIYLGYNNLSGEIPYQIGGLSSLNHLDLVYN 251
Cdd:PLN00113  167 KVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 252 NLSGPIPPSLGDLKKLEYMFLYQNKLSGQIPPSIFSLQNLISLDFSDNSLSGEIPELVAQMQSLEILHLFSNNLTGKIPE 331
Cdd:PLN00113  247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 332 GVTSLPRLKVLQLWSNRFSGGIPANLGKHNNLTVLDLSTNNLTGKLPDTLCDSGHLTKLILFSNSLDSQIPPSLGMCQSL 411
Cdd:PLN00113  327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSL 406
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 412 ERVRLQNNGFSGKLPRGFTKLQLVNFLDLSNNNLQGNINT--WDMPQLEMLDLSVNKFFGELPDFSRSKRLKKLDLSRNK 489
Cdd:PLN00113  407 RRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSrkWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQ 486
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 490 ISGVVPQGLMTFPEIMDLDLSENEITGVIPRELSSCKNLVNLDLSHNNFTGEIPSSFAEFQVLSDLDLSCNQLSGEIPKN 569
Cdd:PLN00113  487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKN 566
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 570 LGNIESLVQVNISHNLLHGSLPFTGAFLAINATAVEGNIDLCSENSASGLRPCKVVRKrsTKSWWLIITSTFAAFLAVLV 649
Cdd:PLN00113  567 LGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK--TPSWWFYITCTLGAFLVLAL 644
                         650       660       670       680       690       700       710       720
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 650 SGFfiVLVFQRTHNVLEVKKVEQEDGTkWETQFFDSKFMKSFTVNTILSSLKDQNVLVD------------KNGVHFVVK 717
Cdd:PLN00113  645 VAF--GFVFIRGRNNLELKRVENEDGT-WELQFFDSKVSKSITINDILSSLKEENVISRgkkgasykgksiKNGMQFVVK 721
                         730       740       750       760       770       780       790       800
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 718 EVKKYDSLPEM-ISDMRKLsDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSGLSWERRRKIMKGIVEALRFLHCRC 796
Cdd:PLN00113  722 EINDVNSIPSSeIADMGKL-QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRC 800
                         810       820       830       840       850       860       870       880
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 797 SPAVVAGNLSPENIVIDVTDEPRLCLGLPGLLCMD------AAYMAPETREHKEMTSKSDIYGFGILLLHLLTGKCSSsn 870
Cdd:PLN00113  801 SPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDtkcfisSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA-- 878
                         890       900       910       920       930       940       950       960
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 871 eDIESGVNGSLVKWARYSYSNCHIDTWIDSSI--DTSVHQREIVHVMNLALKCTAIDPQERPCTNNVLQALESTSSSSSS 948
Cdd:PLN00113  879 -DAEFGVHGSIVEWARYCYSDCHLDMWIDPSIrgDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957
                         970
                  ....*....|..
gi 1780598599 949 CTTYLsKILSLA 960
Cdd:PLN00113  958 CVTGL-KFSSLF 968
LRR COG4886
Leucine-rich repeat (LRR) protein [Transcription];
26-401 1.15e-33

Leucine-rich repeat (LRR) protein [Transcription];


Pssm-ID: 443914 [Multi-domain]  Cd Length: 414  Bit Score: 134.68  E-value: 1.15e-33
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  26 CLHANELELLLSFKSSIQDPLKHLSSWSYSSTNDVCLWSGVVCNNISRVVSLDLSGKNMSGQILTAATFRLPFLQTINLS 105
Cdd:COG4886     1 LLLLLLSLTLKLLLLLLLELLTTLILLLLLLLLLLALLLLSLLSLLLLLTLLLSLLLRDLLLSSLLLLLSLLLLLLLSLL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 106 NNNLSGPIPHDIftTSSPSLRYLNLSNNNFSGSiprgfLPNLYTLDLSNNMFTgEIYNDIGVFSNLRVLDLGGNVLTgHV 185
Cdd:COG4886    81 LLSLLLLGLTDL--GDLTNLTELDLSGNEELSN-----LTNLESLDLSGNQLT-DLPEELANLTNLKELDLSNNQLT-DL 151
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 186 PGYLGNLSRLEFLTLASNQLTGgVPVELGKMKNLKWIYLGYNNLSgEIPYQIGGLSSLNHLDLVYNNLSgPIPPSLGDLK 265
Cdd:COG4886   152 PEPLGNLTNLKSLDLSNNQLTD-LPEELGNLTNLKELDLSNNQIT-DLPEPLGNLTNLEELDLSGNQLT-DLPEPLANLT 228
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 266 KLEYMFLYQNKLSGqiPPSIFSLQNLISLDFSDNSLSgEIPELvAQMQSLEILHLFSNNLTGKIPEGVTSLPRLKVLQLW 345
Cdd:COG4886   229 NLETLDLSNNQLTD--LPELGNLTNLEELDLSNNQLT-DLPPL-ANLTNLKTLDLSNNQLTDLKLKELELLLGLNSLLLL 304
                         330       340       350       360       370
                  ....*....|....*....|....*....|....*....|....*....|....*.
gi 1780598599 346 SNRFSGGIPANLGKHNNLTVLDLSTNNLTGKLPDTLCDSGHLTKLILFSNSLDSQI 401
Cdd:COG4886   305 LLLLNLLELLILLLLLTTLLLLLLLLKGLLVTLTTLALSLSLLALLTLLLLLNLLS 360
STKc_IRAK cd14066
Catalytic domain of the Serine/Threonine kinases, Interleukin-1 Receptor Associated Kinases ...
709-940 7.28e-33

Catalytic domain of the Serine/Threonine kinases, Interleukin-1 Receptor Associated Kinases and related STKs; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. IRAKs are involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) signalling pathways, and are thus critical in regulating innate immune responses and inflammation. Some IRAKs may also play roles in T- and B-cell signaling, and adaptive immunity. Vertebrates contain four IRAKs (IRAK-1, -2, -3 (or -M), and -4) that display distinct functions and patterns of expression and subcellular distribution, and can differentially mediate TLR signaling. IRAK-1, -2, and -4 are ubiquitously expressed and are active kinases, while IRAK-M is only induced in monocytes and macrophages and is an inactive kinase. Variations in IRAK genes are linked to diverse diseases including infection, sepsis, cancer, and autoimmune diseases. IRAKs contain an N-terminal Death domain (DD), a proST region (rich in serines, prolines, and threonines), a central kinase domain (a pseudokinase domain in the case of IRAK3), and a C-terminal domain; IRAK-4 lacks the C-terminal domain. This subfamily includes plant receptor-like kinases (RLKs) including Arabidopsis thaliana BAK1 and CLAVATA1 (CLV1). BAK1 functions in BR (brassinosteroid)-regulated plant development and in pathways involved in plant resistance to pathogen infection and herbivore attack. CLV1, directly binds small signaling peptides, CLAVATA3 (CLV3) and CLAVATA3/EMBRYO SURROUNDING REGI0N (CLE), to restrict stem cell proliferation: the CLV3-CLV1-WUS (WUSCHEL) module influences stem cell maintenance in the shoot apical meristem, and the CLE40 (CLAVATA3/EMBRYO SURROUNDING REGION40) -ACR4 (CRINKLY4) -CLV1- WOX5 (WUSCHEL-RELATED HOMEOBOX5) module at the root apical meristem. The IRAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270968 [Multi-domain]  Cd Length: 272  Bit Score: 128.54  E-value: 7.28e-33
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 709 KNGVHFVVK---------EVKKYDSLPEMISDMRklsdHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG------L 773
Cdd:cd14066    15 ENGTVVAVKrlnemncaaSKKEFLTELEMLGRLR----HPNLVRLLGYCLESDEKLLVYEYMPNGSLEDRLHChkgsppL 90
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 774 SWERRRKIMKGIVEALRFLHCRCSPAVVAGNLSPENIVID------VTD-------EPRLCLGLPGLLCMDAAYMAPETR 840
Cdd:cd14066    91 PWPQRLKIAKGIARGLEYLHEECPPPIIHGDIKSSNILLDedfepkLTDfglarliPPSESVSKTSAVKGTIGYLAPEYI 170
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 841 EHKEMTSKSDIYGFGILLLHLLTGKCSSSNEDIESGVNgSLVKWARYSYSNC---HIDTWIDSsiDTSVHQREIVHVMNL 917
Cdd:cd14066   171 RTGRVSTKSDVYSFGVVLLELLTGKPAVDENRENASRK-DLVEWVESKGKEEledILDKRLVD--DDGVEEEEVEALLRL 247
                         250       260
                  ....*....|....*....|...
gi 1780598599 918 ALKCTAIDPQERPCTNNVLQALE 940
Cdd:cd14066   248 ALLCTRSDPSLRPSMKEVVQMLE 270
LRR COG4886
Leucine-rich repeat (LRR) protein [Transcription];
195-554 2.27e-27

Leucine-rich repeat (LRR) protein [Transcription];


Pssm-ID: 443914 [Multi-domain]  Cd Length: 414  Bit Score: 116.19  E-value: 2.27e-27
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 195 LEFLTLASNQLTGGVPVELGKMKNLKWIYLGYNNLSGEIPYQIGGLSSLNHLDLVYNNLSGPIPPSLGDLKKLEYMFLYQ 274
Cdd:COG4886     2 LLLLLSLTLKLLLLLLLELLTTLILLLLLLLLLLALLLLSLLSLLLLLTLLLSLLLRDLLLSSLLLLLSLLLLLLLSLLL 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 275 NKLSGQIPPSIFSLQNLISLDFSDNslsgeipELVAQMQSLEILHLFSNNLTgKIPEGVTSLPRLKVLQLWSNRFSGgIP 354
Cdd:COG4886    82 LSLLLLGLTDLGDLTNLTELDLSGN-------EELSNLTNLESLDLSGNQLT-DLPEELANLTNLKELDLSNNQLTD-LP 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 355 ANLGKHNNLTVLDLSTNNLTGkLPDTLCDSGHLTKLILFSNSLdSQIPPSLGMCQSLERVRLQNNGFSgKLPRGFTKLQL 434
Cdd:COG4886   153 EPLGNLTNLKSLDLSNNQLTD-LPEELGNLTNLKELDLSNNQI-TDLPEPLGNLTNLEELDLSGNQLT-DLPEPLANLTN 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 435 VNFLDLSNNNLQGNINTWDMPQLEMLDLSVNKFfGELPDFSRSKRLKKLDLSRNKISGVVPQGLMTFPEIMDLDLSENEI 514
Cdd:COG4886   230 LETLDLSNNQLTDLPELGNLTNLEELDLSNNQL-TDLPPLANLTNLKTLDLSNNQLTDLKLKELELLLGLNSLLLLLLLL 308
                         330       340       350       360
                  ....*....|....*....|....*....|....*....|
gi 1780598599 515 TGVIPRELSSCKNLVNLDLSHNNFTGEIPSSFAEFQVLSD 554
Cdd:COG4886   309 NLLELLILLLLLTTLLLLLLLLKGLLVTLTTLALSLSLLA 348
LRR COG4886
Leucine-rich repeat (LRR) protein [Transcription];
251-681 4.59e-24

Leucine-rich repeat (LRR) protein [Transcription];


Pssm-ID: 443914 [Multi-domain]  Cd Length: 414  Bit Score: 106.17  E-value: 4.59e-24
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 251 NNLSGPIPPSLGDLKKLEYMFLYQNKLSGQIPPSIFSLQNLISLDFSDNSLSGEIPELVAQMQSLEILHLFSNNLTGKI- 329
Cdd:COG4886     8 LTLKLLLLLLLELLTTLILLLLLLLLLLALLLLSLLSLLLLLTLLLSLLLRDLLLSSLLLLLSLLLLLLLSLLLLSLLLl 87
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 330 -PEGVTSLPRLKVLQLWSNRfsggipaNLGKHNNLTVLDLSTNNLTgKLPDTLCDSGHLTKLILFSNSLdSQIPPSLGMC 408
Cdd:COG4886    88 gLTDLGDLTNLTELDLSGNE-------ELSNLTNLESLDLSGNQLT-DLPEELANLTNLKELDLSNNQL-TDLPEPLGNL 158
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 409 QSLERVRLQNNGFSGkLPRGFTKLQLVNFLDLSNNNLQgnintwdmpqlemldlsvnkffgELPD-FSRSKRLKKLDLSR 487
Cdd:COG4886   159 TNLKSLDLSNNQLTD-LPEELGNLTNLKELDLSNNQIT-----------------------DLPEpLGNLTNLEELDLSG 214
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 488 NKISgVVPQGLMTFPEIMDLDLSENEITgVIPrELSSCKNLVNLDLSHNNFTgEIPSSfAEFQVLSDLDLSCNQLSGEIP 567
Cdd:COG4886   215 NQLT-DLPEPLANLTNLETLDLSNNQLT-DLP-ELGNLTNLEELDLSNNQLT-DLPPL-ANLTNLKTLDLSNNQLTDLKL 289
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 568 KNLGNIESLVQVNISHNLLHGSLPFTGAFLAINATAVEGNIDLCSENSASGLRPCKVVRKRSTKSWWLIITSTFAAFLAV 647
Cdd:COG4886   290 KELELLLGLNSLLLLLLLLNLLELLILLLLLTTLLLLLLLLKGLLVTLTTLALSLSLLALLTLLLLLNLLSLLLTLLLTL 369
                         410       420       430
                  ....*....|....*....|....*....|....
gi 1780598599 648 LVSGFFIVLVFQRTHNVLEVKKVEQEDGTKWETQ 681
Cdd:COG4886   370 GLLGLLEATLLTLALLLLTLLLLLLTTTAGVLLL 403
STK_BAK1_like cd14664
Catalytic domain of the Serine/Threonine Kinase, BRI1 associated kinase 1 and related STKs; ...
727-940 8.78e-24

Catalytic domain of the Serine/Threonine Kinase, BRI1 associated kinase 1 and related STKs; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily includes three leucine-rich repeat receptor-like kinases (LRR-RLKs): Arabidopsis thaliana BAK1 and CLAVATA1 (CLV1), and Physcomitrella patens CLL1B clavata1-like receptor S/T protein kinase. BAK1 functions in various signaling pathways. It plays a role in BR (brassinosteroid)-regulated plant development as a co-receptor of BRASSINOSTEROID (BR) INSENSITIVE 1 (BRI1), the receptor for BRs, and is required for full activation of BR signaling. It also modulates pathways involved in plant resistance to pathogen infection (pattern-triggered immunity, PTI) and herbivore attack (wound- or herbivore feeding-induced accumulation of jasmonic acid (JA) and JA-isoleucine. CLV1, directly binds small signaling peptides, CLAVATA3 (CLV3) and CLAVATA3/EMBRYO SURROUNDING REGI0N (CLE), to restrict stem cell proliferation: the CLV3-CLV1-WUS (WUSCHEL) module influences stem cell maintenance in the shoot apical meristem, and the CLE40 (CLAVATA3/EMBRYO SURROUNDING REGION40) -ACR4 (CRINKLY4) -CLV1- WOX5 (WUSCHEL-RELATED HOMEOBOX5) module at the root apical meristem. The STK_BAK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271134 [Multi-domain]  Cd Length: 270  Bit Score: 102.19  E-value: 8.78e-24
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 727 EMISDMRklsdHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG-------LSWERRRKIMKGIVEALRFLHCRCSPA 799
Cdd:cd14664    42 QTLGMIR----HRNIVRLRGYCSNPTTNLLVYEYMPNGSLGELLHSrpesqppLDWETRQRIALGSARGLAYLHHDCSPL 117
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 800 VVAGNLSPENIVIDVTDEPRLCLGLPGLLCMDAA------------YMAPETREHKEMTSKSDIYGFGILLLHLLTGKCS 867
Cdd:cd14664   118 IIHRDVKSNNILLDEEFEAHVADFGLAKLMDDKDshvmssvagsygYIAPEYAYTGKVSEKSDVYSYGVVLLELITGKRP 197
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1780598599 868 SSNEDIESGVNgsLVKWARYSYSNCHIDTWIDSSIDTSVHQREIVHVMNLALKCTAIDPQERPCTNNVLQALE 940
Cdd:cd14664   198 FDEAFLDDGVD--IVDWVRGLLEEKKVEALVDPDLQGVYKLEEVEQVFQVALLCTQSSPMERPTMREVVRMLE 268
STKc_PknB_like cd14014
Catalytic domain of bacterial Serine/Threonine kinases, PknB and similar proteins; STKs ...
732-940 7.13e-19

Catalytic domain of bacterial Serine/Threonine kinases, PknB and similar proteins; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily includes many bacterial eukaryotic-type STKs including Staphylococcus aureus PknB (also called PrkC or Stk1), Bacillus subtilis PrkC, and Mycobacterium tuberculosis Pkn proteins (PknB, PknD, PknE, PknF, PknL, and PknH), among others. S. aureus PknB is the only eukaryotic-type STK present in this species, although many microorganisms encode for several such proteins. It is important for the survival and pathogenesis of S. aureus as it is involved in the regulation of purine and pyrimidine biosynthesis, cell wall metabolism, autolysis, virulence, and antibiotic resistance. M. tuberculosis PknB is essential for growth and it acts on diverse substrates including proteins involved in peptidoglycan synthesis, cell division, transcription, stress responses, and metabolic regulation. B. subtilis PrkC is located at the inner membrane of endospores and functions to trigger spore germination. Bacterial STKs in this subfamily show varied domain architectures. The well-characterized members such as S. aureus and M. tuberculosis PknB, and B. subtilis PrkC, contain an N-terminal cytosolic kinase domain, a transmembrane (TM) segment, and mutliple C-terminal extracellular PASTA domains. The PknB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270916 [Multi-domain]  Cd Length: 260  Bit Score: 87.26  E-value: 7.13e-19
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 732 MRKLSdHKNILKIVATCRSETVAYLIHEDVEGKRLSQVL---SGLSWERRRKIMKGIVEALRFLHcrcSPAVVAGNLSPE 808
Cdd:cd14014    54 LARLS-HPNIVRVYDVGEDDGRPYIVMEYVEGGSLADLLrerGPLPPREALRILAQIADALAAAH---RAGIVHRDIKPA 129
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 809 NIVID------VTD------EPRLCLGLPGLLCMDAAYMAPETREHKEMTSKSDIYGFGILLLHLLTGK----CSSSNED 872
Cdd:cd14014   130 NILLTedgrvkLTDfgiaraLGDSGLTQTGSVLGTPAYMAPEQARGGPVDPRSDIYSLGVVLYELLTGRppfdGDSPAAV 209
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1780598599 873 IESGVNGSLVKWARYsysNCHIDTWIDssidtsvhqreivhvmNLALKCTAIDPQERPCTNN-VLQALE 940
Cdd:cd14014   210 LAKHLQEAPPPPSPL---NPDVPPALD----------------AIILRALAKDPEERPQSAAeLLAALR 259
SPS1 COG0515
Serine/threonine protein kinase [Signal transduction mechanisms];
737-930 2.26e-18

Serine/threonine protein kinase [Signal transduction mechanisms];


Pssm-ID: 440281 [Multi-domain]  Cd Length: 482  Bit Score: 89.30  E-value: 2.26e-18
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 737 DHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG---LSWERRRKIMKGIVEALRFLHCRCspaVVAGNLSPENIVID 813
Cdd:COG0515    65 NHPNIVRVYDVGEEDGRPYLVMEYVEGESLADLLRRrgpLPPAEALRILAQLAEALAAAHAAG---IVHRDIKPANILLT 141
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 814 ------VTD------EPRLCLGLPGLLCMDAAYMAPETREHKEMTSKSDIYGFGILLLHLLTGK----CSSSNEDIESGV 877
Cdd:COG0515   142 pdgrvkLIDfgiaraLGGATLTQTGTVVGTPGYMAPEQARGEPVDPRSDVYSLGVTLYELLTGRppfdGDSPAELLRAHL 221
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|...
gi 1780598599 878 NGSLVKWARYsysNCHIDTWIDssidtsvhqrEIVhvmnlaLKCTAIDPQERP 930
Cdd:COG0515   222 REPPPPPSEL---RPDLPPALD----------AIV------LRALAKDPEERY 255
STKc_MAP3K-like cd13999
Catalytic domain of Mitogen-Activated Protein Kinase (MAPK) Kinase Kinase-like Serine ...
716-939 3.05e-17

Catalytic domain of Mitogen-Activated Protein Kinase (MAPK) Kinase Kinase-like Serine/Threonine kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed mainly of MAP3Ks and similar proteins, including TGF-beta Activated Kinase-1 (TAK1, also called MAP3K7), MAP3K12, MAP3K13, Mixed lineage kinase (MLK), MLK-Like mitogen-activated protein Triple Kinase (MLTK), and Raf (Rapidly Accelerated Fibrosarcoma) kinases. MAP3Ks (MKKKs or MAPKKKs) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Also included in this subfamily is the pseudokinase Kinase Suppressor of Ras (KSR), which is a scaffold protein that functions downstream of Ras and upstream of Raf in the Extracellular signal-Regulated Kinase (ERK) pathway.


Pssm-ID: 270901 [Multi-domain]  Cd Length: 245  Bit Score: 82.20  E-value: 3.05e-17
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 716 VKEVKKYDSLPEMISD-------MRKLSdHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG----LSWERRRKIMKG 784
Cdd:cd13999    21 IKKLKVEDDNDELLKEfrrevsiLSKLR-HPNIVQFIGACLSPPPLCIVTEYMPGGSLYDLLHKkkipLSWSLRLKIALD 99
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 785 IVEALRFLHcrcSPAVVAGNLSPENIVID------VTDEPRLCLGLPGLLCMDA-----AYMAPETREHKEMTSKSDIYG 853
Cdd:cd13999   100 IARGMNYLH---SPPIIHRDLKSLNILLDenftvkIADFGLSRIKNSTTEKMTGvvgtpRWMAPEVLRGEPYTEKADVYS 176
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 854 FGILLLHLLTGKCS----SSNEDIESGVNGSLVkwaRYSYSNCHIDtwidssidtsvhqreivhVMNLALKCTAIDPQER 929
Cdd:cd13999   177 FGIVLWELLTGEVPfkelSPIQIAAAVVQKGLR---PPIPPDCPPE------------------LSKLIKRCWNEDPEKR 235
                         250
                  ....*....|
gi 1780598599 930 PCTNNVLQAL 939
Cdd:cd13999   236 PSFSEIVKRL 245
LRR COG4886
Leucine-rich repeat (LRR) protein [Transcription];
70-326 2.37e-16

Leucine-rich repeat (LRR) protein [Transcription];


Pssm-ID: 443914 [Multi-domain]  Cd Length: 414  Bit Score: 82.67  E-value: 2.37e-16
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  70 NISRVVSLDLSGKNMSgqILTAATFRLPFLQTINLSNNNLSGpIPHDIFttSSPSLRYLNLSNNNFSgSIPRGF--LPNL 147
Cdd:COG4886   134 NLTNLKELDLSNNQLT--DLPEPLGNLTNLKSLDLSNNQLTD-LPEELG--NLTNLKELDLSNNQIT-DLPEPLgnLTNL 207
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 148 YTLDLSNNMFTgEIYNDIGVFSNLRVLDLGGNVLTgHVPgYLGNLSRLEFLTLASNQLTGgVPvELGKMKNLKWIYLGYN 227
Cdd:COG4886   208 EELDLSGNQLT-DLPEPLANLTNLETLDLSNNQLT-DLP-ELGNLTNLEELDLSNNQLTD-LP-PLANLTNLKTLDLSNN 282
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 228 NLSGEIPYQIGGLSSLNHLDLVYNNLSGPIPPSLGDLKKLEYMFLYQNKLSGQIPPSIFSLQNLISLDFSDNSLSGEIPE 307
Cdd:COG4886   283 QLTDLKLKELELLLGLNSLLLLLLLLNLLELLILLLLLTTLLLLLLLLKGLLVTLTTLALSLSLLALLTLLLLLNLLSLL 362
                         250
                  ....*....|....*....
gi 1780598599 308 LVAQMQSLEILHLFSNNLT 326
Cdd:COG4886   363 LTLLLTLGLLGLLEATLLT 381
PLN03150 PLN03150
hypothetical protein; Provisional
483-682 1.08e-14

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 78.32  E-value: 1.08e-14
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 483 LDLSRNKISGVVPQGLMTFPEIMDLDLSENEITGVIPRELSSCKNLVNLDLSHNNFTGEIPSSFAEFQVLSDLDLSCNQL 562
Cdd:PLN03150  423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 563 SGEIPKNLGNieslvqvnishNLLHG-SLPFTgaflainataveGNIDLCsenSASGLRPCKVVRKRSTKswwliITSTF 641
Cdd:PLN03150  503 SGRVPAALGG-----------RLLHRaSFNFT------------DNAGLC---GIPGLRACGPHLSVGAK-----IGIAF 551
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|...
gi 1780598599 642 AAFLAVLVSGFFIVLVFQRTHNVLEVKKVEQEDG--TKWETQF 682
Cdd:PLN03150  552 GVSVAFLFLVICAMCWWKRRQNILRAQRIAAREApyAKARTHF 594
PLN03150 PLN03150
hypothetical protein; Provisional
198-308 5.56e-14

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 76.01  E-value: 5.56e-14
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 198 LTLASNQLTGGVPVELGKMKNLKWIYLGYNNLSGEIPYQIGGLSSLNHLDLVYNNLSGPIPPSLGDLKKLEYMFLYQNKL 277
Cdd:PLN03150  423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502
                          90       100       110
                  ....*....|....*....|....*....|...
gi 1780598599 278 SGQIPPSIFS-LQNLISLDFSDNS-LSGeIPEL 308
Cdd:PLN03150  503 SGRVPAALGGrLLHRASFNFTDNAgLCG-IPGL 534
PLN03150 PLN03150
hypothetical protein; Provisional
30-190 9.24e-14

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 75.24  E-value: 9.24e-14
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  30 NELELLLSFKSSIQDPLKHlsSWSysstNDVCL-----WSGVVC---NNISR--VVSLDLSGKNMSGQILTAATfRLPFL 99
Cdd:PLN03150  372 EEVSALQTLKSSLGLPLRF--GWN----GDPCVpqqhpWSGADCqfdSTKGKwfIDGLGLDNQGLRGFIPNDIS-KLRHL 444
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 100 QTINLSNNNLSGPIPHDIFTTSspSLRYLNLSNNNFSGSIPrgflpnlytldlsnnmftgeiyNDIGVFSNLRVLDLGGN 179
Cdd:PLN03150  445 QSINLSGNSIRGNIPPSLGSIT--SLEVLDLSYNSFNGSIP----------------------ESLGQLTSLRILNLNGN 500
                         170
                  ....*....|.
gi 1780598599 180 VLTGHVPGYLG 190
Cdd:PLN03150  501 SLSGRVPAALG 511
PLN03150 PLN03150
hypothetical protein; Provisional
277-358 1.43e-13

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 74.85  E-value: 1.43e-13
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 277 LSGQIPPSIFSLQNLISLDFSDNSLSGEIPELVAQMQSLEILHLFSNNLTGKIPEGVTSLPRLKVLQLWSNRFSGGIPAN 356
Cdd:PLN03150  430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509

                  ..
gi 1780598599 357 LG 358
Cdd:PLN03150  510 LG 511
PLN03150 PLN03150
hypothetical protein; Provisional
246-337 1.78e-13

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 74.47  E-value: 1.78e-13
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 246 LDLVYNNLSGPIPPSLGDLKKLEYMFLYQNKLSGQIPPSIFSLQNLISLDFSDNSLSGEIPELVAQMQSLEILHLFSNNL 325
Cdd:PLN03150  423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502
                          90
                  ....*....|..
gi 1780598599 326 TGKIPEGVTSLP 337
Cdd:PLN03150  503 SGRVPAALGGRL 514
PLN03150 PLN03150
hypothetical protein; Provisional
150-240 3.93e-13

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 73.31  E-value: 3.93e-13
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 150 LDLSNNMFTGEIYNDIGVFSNLRVLDLGGNVLTGHVPGYLGNLSRLEFLTLASNQLTGGVPVELGKMKNLKWIYLGYNNL 229
Cdd:PLN03150  423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502
                          90
                  ....*....|.
gi 1780598599 230 SGEIPYQIGGL 240
Cdd:PLN03150  503 SGRVPAALGGR 513
Pkinase pfam00069
Protein kinase domain;
709-930 5.25e-13

Protein kinase domain;


Pssm-ID: 459660 [Multi-domain]  Cd Length: 217  Bit Score: 69.19  E-value: 5.25e-13
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 709 KNGVHFVVKEVKKYDSLPEM-------ISDMRKLSdHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLS---GLSWERR 778
Cdd:pfam00069  22 DTGKIVAIKKIKKEKIKKKKdknilreIKILKKLN-HPNIVRLYDAFEDKDNLYLVLEYVEGGSLFDLLSekgAFSEREA 100
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 779 RKIMKGIVEALRFLHCRCSPAVvagnlSPEnividvtdeprlclglpgllcmdaaYMAPETREHKEMTSKSDIYGFGILL 858
Cdd:pfam00069 101 KFIMKQILEGLESGSSLTTFVG-----TPW-------------------------YMAPEVLGGNPYGPKVDVWSLGCIL 150
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1780598599 859 LHLLTGK----CSSSNEDIESGVNGSLvkwarysYSNCHIDTWIDSSIDtsvhqreivhvmnLALKCTAIDPQERP 930
Cdd:pfam00069 151 YELLTGKppfpGINGNEIYELIIDQPY-------AFPELPSNLSEEAKD-------------LLKKLLKKDPSKRL 206
STKc_Mos cd13979
Catalytic domain of the Serine/Threonine kinase, Oocyte maturation factor Mos; STKs catalyze ...
738-865 1.31e-12

Catalytic domain of the Serine/Threonine kinase, Oocyte maturation factor Mos; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Mos (or c-Mos) is a germ-cell specific kinase that plays roles in both the release of primary arrest and the induction of secondary arrest in oocytes. It is expressed towards the end of meiosis I and is quickly degraded upon fertilization. It is a component of the cytostatic factor (CSF), which is responsible for metaphase II arrest. In addition, Mos activates a phoshorylation cascade that leads to the activation of the p34 subunit of MPF (mitosis-promoting factor or maturation promoting factor), a cyclin-dependent kinase that is responsible for the release of primary arrest in meiosis I. The Mos subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270881 [Multi-domain]  Cd Length: 265  Bit Score: 68.95  E-value: 1.31e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 738 HKNILKIVAT---CRSETVAYLIHEDVEGKRLSQVLSG----LSWERRRKIMKGIVEALRFLHCRcspAVVAGNLSPENI 810
Cdd:cd13979    58 HENIVRVLAAetgTDFASLGLIIMEYCGNGTLQQLIYEgsepLPLAHRILISLDIARALRFCHSH---GIVHLDVKPANI 134
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1780598599 811 VIDVTD--------------EPRLCLGLPGLLCMDAAYMAPETREHKEMTSKSDIYGFGILLLHLLTGK 865
Cdd:cd13979   135 LISEQGvcklcdfgcsvklgEGNEVGTPRSHIGGTYTYRAPELLKGERVTPKADIYSFGITLWQMLTRE 203
LRR COG4886
Leucine-rich repeat (LRR) protein [Transcription];
76-320 2.22e-12

Leucine-rich repeat (LRR) protein [Transcription];


Pssm-ID: 443914 [Multi-domain]  Cd Length: 414  Bit Score: 69.96  E-value: 2.22e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  76 SLDLSGKNMSGqiLTAATFRLPFLQTINLSNNNLSgPIPHDIftTSSPSLRYLNLSNNNFSgSIPRGF--LPNLYTLDLS 153
Cdd:COG4886   163 SLDLSNNQLTD--LPEELGNLTNLKELDLSNNQIT-DLPEPL--GNLTNLEELDLSGNQLT-DLPEPLanLTNLETLDLS 236
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 154 NNMFTgEIYNdIGVFSNLRVLDLGGNVLTgHVPGyLGNLSRLEFLTLASNQLTGGVPVELGKMKNLKWIYLGYNNLSGEI 233
Cdd:COG4886   237 NNQLT-DLPE-LGNLTNLEELDLSNNQLT-DLPP-LANLTNLKTLDLSNNQLTDLKLKELELLLGLNSLLLLLLLLNLLE 312
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 234 PYQIGGLSSLNHLDLVYNNLSGPIPPSLGDLKKLEYMFLYQNKLSGQIPPSIFSLQNLISLDFSDNSLSGEIPELVAQMQ 313
Cdd:COG4886   313 LLILLLLLTTLLLLLLLLKGLLVTLTTLALSLSLLALLTLLLLLNLLSLLLTLLLTLGLLGLLEATLLTLALLLLTLLLL 392

                  ....*..
gi 1780598599 314 SLEILHL 320
Cdd:COG4886   393 LLTTTAG 399
STKc_TAK1 cd14058
Catalytic domain of the Serine/Threonine Kinase, Transforming Growth Factor beta Activated ...
719-940 3.70e-12

Catalytic domain of the Serine/Threonine Kinase, Transforming Growth Factor beta Activated Kinase-1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. TAK1 is also known as mitogen-activated protein kinase kinase kinase 7 (MAPKKK7 or MAP3K7), TAK, or MEKK7. As a MAPKKK, it is an important mediator of cellular responses to extracellular signals. It regulates both the c-Jun N-terminal kinase and p38 MAPK cascades by activating the MAPK kinases, MKK4 and MKK3/6. In addition, TAK1 plays diverse roles in immunity and development, in different biological contexts, through many signaling pathways including TGFbeta/BMP, Wnt/Fz, and NF-kB. It is also implicated in the activation of the tumor suppressor kinase, LKB1. The TAK1 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270960 [Multi-domain]  Cd Length: 253  Bit Score: 67.46  E-value: 3.70e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 719 VKKYDSLPE---MISDMRKLS--DHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG------------LSWERRrki 781
Cdd:cd14058    21 VKIIESESEkkaFEVEVRQLSrvDHPNIIKLYGACSNQKPVCLVMEYAEGGSLYNVLHGkepkpiytaahaMSWALQ--- 97
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 782 mkgIVEALRFLHCRCSPAVVAGNLSPENI-------VIDVTDEPRLCLGLPGLLCM--DAAYMAPETREHKEMTSKSDIY 852
Cdd:cd14058    98 ---CAKGVAYLHSMKPKALIHRDLKPPNLlltnggtVLKICDFGTACDISTHMTNNkgSAAWMAPEVFEGSKYSEKCDVF 174
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 853 GFGILLLHLLTGKCSSSnediESGVNGSLVKWARYSYSNCHIDTWIDSSIDtsvhqreivhvmNLALKCTAIDPQERPCT 932
Cdd:cd14058   175 SWGIILWEVITRRKPFD----HIGGPAFRIMWAVHNGERPPLIKNCPKPIE------------SLMTRCWSKDPEKRPSM 238

                  ....*...
gi 1780598599 933 NNVLQALE 940
Cdd:cd14058   239 KEIVKIMS 246
PLN03150 PLN03150
hypothetical protein; Provisional
294-381 4.19e-12

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 69.84  E-value: 4.19e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 294 LDFSDNSLSGEIPELVAQMQSLEILHLFSNNLTGKIPEGVTSLPRLKVLQLWSNRFSGGIPANLGKHNNLTVLDLSTNNL 373
Cdd:PLN03150  423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502

                  ....*...
gi 1780598599 374 TGKLPDTL 381
Cdd:PLN03150  503 SGRVPAAL 510
LRR_RI cd00116
Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 ...
246-515 7.36e-12

Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).


Pssm-ID: 238064 [Multi-domain]  Cd Length: 319  Bit Score: 67.77  E-value: 7.36e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 246 LDLVYNNLSGP----IPPSLGDLKKLEYMFLYQNKLsGQIPPSIFSL-QNLIS------LDFSDNSLSGEIPELVA---Q 311
Cdd:cd00116    28 LRLEGNTLGEEaakaLASALRPQPSLKELCLSLNET-GRIPRGLQSLlQGLTKgcglqeLDLSDNALGPDGCGVLEsllR 106
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 312 MQSLEILHLfSNNLTGK-----IPEGVTSL-PRLKVLQLWSNRFSGGIPANLGK----HNNLTVLDLSTNNLTGKLPDTL 381
Cdd:cd00116   107 SSSLQELKL-NNNGLGDrglrlLAKGLKDLpPALEKLVLGRNRLEGASCEALAKalraNRDLKELNLANNGIGDAGIRAL 185
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 382 CdsghltklilfsnsldsqipPSLGMCQSLERVRLQNNGF----SGKLPRGFTKLQLVNFLDLSNNNLQgnintwDMPQL 457
Cdd:cd00116   186 A--------------------EGLKANCNLEVLDLNNNGLtdegASALAETLASLKSLEVLNLGDNNLT------DAGAA 239
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1780598599 458 EMLDLSVnkffgelpdfSRSKRLKKLDLSRNKI--SGV--VPQGLMTFPEIMDLDLSENEIT 515
Cdd:cd00116   240 ALASALL----------SPNISLLTLSLSCNDItdDGAkdLAEVLAEKESLLELDLRGNKFG 291
S_TKc smart00220
Serine/Threonine protein kinases, catalytic domain; Phosphotransferases. Serine or ...
709-937 1.60e-11

Serine/Threonine protein kinases, catalytic domain; Phosphotransferases. Serine or threonine-specific kinase subfamily.


Pssm-ID: 214567 [Multi-domain]  Cd Length: 254  Bit Score: 65.63  E-value: 1.60e-11
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  709 KNGVHFVVKEVKK--YDSLPEM----ISDMRKLsDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLS---GLSWERRR 779
Cdd:smart00220  22 KTGKLVAIKVIKKkkIKKDRERilreIKILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKkrgRLSEDEAR 100
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  780 KIMKGIVEALRFLHCRCspaVVAGNLSPENIVIDVTDEP--------RLCLGLPGLLCMD--AAYMAPETREHKEMTSKS 849
Cdd:smart00220 101 FYLRQILSALEYLHSKG---IVHRDLKPENILLDEDGHVkladfglaRQLDPGEKLTTFVgtPEYMAPEVLLGKGYGKAV 177
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  850 DIYGFGILLLHLLTGK--CSSSNEDIEsgvngsLVKWARYSYSNCHIDTWIDSSidtsvhqreivHVMNLALKCTAIDPQ 927
Cdd:smart00220 178 DIWSLGVILYELLTGKppFPGDDQLLE------LFKKIGKPKPPFPPPEWDISP-----------EAKDLIRKLLVKDPE 240
                          250
                   ....*....|
gi 1780598599  928 ERPCTNNVLQ 937
Cdd:smart00220 241 KRLTAEEALQ 250
PLN03150 PLN03150
hypothetical protein; Provisional
174-262 2.30e-11

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 67.53  E-value: 2.30e-11
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 174 LDLGGNVLTGHVPGYLGNLSRLEFLTLASNQLTGGVPVELGKMKNLKWIYLGYNNLSGEIPYQIGGLSSLNHLDLVYNNL 253
Cdd:PLN03150  423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502

                  ....*....
gi 1780598599 254 SGPIPPSLG 262
Cdd:PLN03150  503 SGRVPAALG 511
PLN03150 PLN03150
hypothetical protein; Provisional
318-406 5.16e-11

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 66.38  E-value: 5.16e-11
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 318 LHLFSNNLTGKIPEGVTSLPRLKVLQLWSNRFSGGIPANLGKHNNLTVLDLSTNNLTGKLPDTLCDSGHLTKLILFSNSL 397
Cdd:PLN03150  423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502

                  ....*....
gi 1780598599 398 DSQIPPSLG 406
Cdd:PLN03150  503 SGRVPAALG 511
STYKc smart00221
Protein kinase; unclassified specificity; Phosphotransferases. The specificity of this class ...
716-939 1.17e-10

Protein kinase; unclassified specificity; Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.


Pssm-ID: 214568 [Multi-domain]  Cd Length: 258  Bit Score: 62.95  E-value: 1.17e-10
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  716 VKEVKKyDSLPEMISD-------MRKLsDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVL-----SGLSWERRRKIMK 783
Cdd:smart00221  33 VKTLKE-DASEQQIEEflreariMRKL-DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLrknrpKELSLSDLLSFAL 110
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  784 GIVEALRFLHCRCspaVVAGNLSPENIVID------VTD------EPRLCLGLPGLLCMDAAYMAPETREHKEMTSKSDI 851
Cdd:smart00221 111 QIARGMEYLESKN---FIHRDLAARNCLVGenlvvkISDfglsrdLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDV 187
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  852 YGFGILLLHLLTGkCSS-----SNEDIESGV-NGSLvkwaRYSYSNCHidtwidssidtsvhqREIVHVMnlaLKCTAID 925
Cdd:smart00221 188 WSFGVLLWEIFTL-GEEpypgmSNAEVLEYLkKGYR----LPKPPNCP---------------PELYKLM---LQCWAED 244
                          250
                   ....*....|....
gi 1780598599  926 PQERPCTNNVLQAL 939
Cdd:smart00221 245 PEDRPTFSELVEIL 258
LRR_RI cd00116
Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 ...
285-565 1.21e-10

Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).


Pssm-ID: 238064 [Multi-domain]  Cd Length: 319  Bit Score: 63.91  E-value: 1.21e-10
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 285 IFSLQNLISLDFSDNSLSGEIPELVAQM----QSLEILHLfSNNLTGKIPEGVTSLPrlkvlqlwsnrfsggipANLGKH 360
Cdd:cd00116    19 LPKLLCLQVLRLEGNTLGEEAAKALASAlrpqPSLKELCL-SLNETGRIPRGLQSLL-----------------QGLTKG 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 361 NNLTVLDLSTNNLTGKLPDTLCD---SGHLTKLILFSNSLDSQIPP----SLGMCQ-SLERVRLQNNGFSGK----LPRG 428
Cdd:cd00116    81 CGLQELDLSDNALGPDGCGVLESllrSSSLQELKLNNNGLGDRGLRllakGLKDLPpALEKLVLGRNRLEGAsceaLAKA 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 429 FTKLQLVNFLDLSNNNLQGnintwdmPQLEMLdlsvnkffgeLPDFSRSKRLKKLDLSRNKI----SGVVPQGLMTFPEI 504
Cdd:cd00116   161 LRANRDLKELNLANNGIGD-------AGIRAL----------AEGLKANCNLEVLDLNNNGLtdegASALAETLASLKSL 223
                         250       260       270       280       290       300       310
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 505 MDLDLSENEITGVIPRELSS-----CKNLVNLDLSHNNFTGEIPSSFAEFQ----VLSDLDLSCNQLSGE 565
Cdd:cd00116   224 EVLNLGDNNLTDAGAAALASallspNISLLTLSLSCNDITDDGAKDLAEVLaekeSLLELDLRGNKFGEE 293
STKc_RIP cd13978
Catalytic domain of the Serine/Threonine kinase, Receptor Interacting Protein; STKs catalyze ...
711-930 1.29e-10

Catalytic domain of the Serine/Threonine kinase, Receptor Interacting Protein; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. RIP kinases serve as essential sensors of cellular stress. They are involved in regulating NF-kappaB and MAPK signaling, and are implicated in mediating cellular processes such as apoptosis, necroptosis, differentiation, and survival. RIP kinases contain a homologous N-terminal kinase domain and varying C-terminal domains. Higher vertebrates contain multiple RIP kinases, with mammals harboring at least five members. RIP1 and RIP2 harbor C-terminal domains from the Death domain (DD) superfamily while RIP4 contains ankyrin (ANK) repeats. RIP3 contain a RIP homotypic interaction motif (RHIM) that facilitates binding to RIP1. RIP1 and RIP3 are important in apoptosis and necroptosis, while RIP2 and RIP4 play roles in keratinocyte differentiation and inflammatory immune responses. The RIP subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270880 [Multi-domain]  Cd Length: 263  Bit Score: 63.24  E-value: 1.29e-10
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 711 GVHFVVKEVKKYDSLPEMISD-------MRKLSdHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSGLS----WERRR 779
Cdd:cd13978    18 FGMVAIKCLHSSPNCIEERKAllkeaekMERAR-HSYVLPLLGVCVERRSLGLVMEYMENGSLKSLLEREIqdvpWSLRF 96
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 780 KIMKGIVEALRFLHCrCSPAVVAGNLSPENIVID------VTD-----EPRLCLGLPGLLCMDA-----AYMAPETRE-- 841
Cdd:cd13978    97 RIIHEIALGMNFLHN-MDPPLLHHDLKPENILLDnhfhvkISDfglskLGMKSISANRRRGTENlggtpIYMAPEAFDdf 175
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 842 HKEMTSKSDIYGFGILLLHLLTGKCSSSNEDIESGVNGSLVKWARysysnCHIDtwidsSIDTSVHQREIVHVMNLALKC 921
Cdd:cd13978   176 NKKPTSKSDVYSFAIVIWAVLTRKEPFENAINPLLIMQIVSKGDR-----PSLD-----DIGRLKQIENVQELISLMIRC 245

                  ....*....
gi 1780598599 922 TAIDPQERP 930
Cdd:cd13978   246 WDGNPDARP 254
TyrKc smart00219
Tyrosine kinase, catalytic domain; Phosphotransferases. Tyrosine-specific kinase subfamily.
716-939 2.44e-10

Tyrosine kinase, catalytic domain; Phosphotransferases. Tyrosine-specific kinase subfamily.


Pssm-ID: 197581 [Multi-domain]  Cd Length: 257  Bit Score: 62.16  E-value: 2.44e-10
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  716 VKEVKKyDSLPEMISD-------MRKLsDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVL----SGLSWERRRKIMKG 784
Cdd:smart00219  33 VKTLKE-DASEQQIEEflreariMRKL-DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLrknrPKLSLSDLLSFALQ 110
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  785 IVEALRFLH-CRCspavVAGNLSPENIVID------VTD------EPRLCLGLPGLLCMDAAYMAPETREHKEMTSKSDI 851
Cdd:smart00219 111 IARGMEYLEsKNF----IHRDLAARNCLVGenlvvkISDfglsrdLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDV 186
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  852 YGFGILLLHLLTGkCSS-----SNEDIESGV-NGSLvkwaRYSYSNCHidtwidssidtsvhqREIVHVMnlaLKCTAID 925
Cdd:smart00219 187 WSFGVLLWEIFTL-GEQpypgmSNEEVLEYLkNGYR----LPQPPNCP---------------PELYDLM---LQCWAED 243
                          250
                   ....*....|....
gi 1780598599  926 PQERPCTNNVLQAL 939
Cdd:smart00219 244 PEDRPTFSELVEIL 257
LRRNT_2 pfam08263
Leucine rich repeat N-terminal domain; Leucine Rich Repeats pfam00560 are short sequence ...
28-69 4.60e-09

Leucine rich repeat N-terminal domain; Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats.


Pssm-ID: 462411 [Multi-domain]  Cd Length: 41  Bit Score: 52.68  E-value: 4.60e-09
                          10        20        30        40
                  ....*....|....*....|....*....|....*....|..
gi 1780598599  28 HANELELLLSFKSSIQDPLKHLSSWSYSSTnDVCLWSGVVCN 69
Cdd:pfam08263   1 LNDDGQALLAFKSSLNDPPGALSSWNSSSS-DPCSWTGVTCD 41
STKc_CAMK cd05117
The catalytic domain of CAMK family Serine/Threonine Kinases; STKs catalyze the transfer of ...
709-937 6.91e-09

The catalytic domain of CAMK family Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CaMKs are multifunctional calcium and calmodulin (CaM) stimulated STKs involved in cell cycle regulation. There are several types of CaMKs including CaMKI, CaMKII, and CaMKIV. CaMKI proteins are monomeric and they play pivotal roles in the nervous system, including long-term potentiation, dendritic arborization, neurite outgrowth, and the formation of spines, synapses, and axons. CaMKII is a signaling molecule that translates upstream calcium and reactive oxygen species (ROS) signals into downstream responses that play important roles in synaptic function and cardiovascular physiology. CAMKIV is implicated in regulating several transcription factors like CREB, MEF2, and retinoid orphan receptors, as well as in T-cell development and signaling. The CAMK family also consists of other related kinases including the Phosphorylase kinase Gamma subunit (PhKG), the C-terminal kinase domains of Ribosomal S6 kinase (RSK) and Mitogen and stress-activated kinase (MSK), Doublecortin-like kinase (DCKL), and the MAPK-activated protein kinases MK2, MK3, and MK5, among others. The CAMK family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270687 [Multi-domain]  Cd Length: 258  Bit Score: 57.87  E-value: 6.91e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 709 KNGVHFVVKEVKKYDSLPEMISD-------MRKLsDHKNILKIVATCRSETVAYLIHEDVEGKRL------SQVLSglsw 775
Cdd:cd05117    23 KTGEEYAVKIIDKKKLKSEDEEMlrreieiLKRL-DHPNIVKLYEVFEDDKNLYLVMELCTGGELfdrivkKGSFS---- 97
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 776 ERR-RKIMKGIVEALRFLHCRCspaVVAGNLSPENIVIDVTDEP-----------RLCLGLPGLLCM--DAAYMAPETRE 841
Cdd:cd05117    98 EREaAKIMKQILSAVAYLHSQG---IVHRDLKPENILLASKDPDspikiidfglaKIFEEGEKLKTVcgTPYYVAPEVLK 174
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 842 HKEMTSKSDIYGFGILLLHLLTGK---CSSSNEDIEsgvngSLVKWARYSYSNchiDTWIDSSidtsvhqreiVHVMNLA 918
Cdd:cd05117   175 GKGYGKKCDIWSLGVILYILLCGYppfYGETEQELF-----EKILKGKYSFDS---PEWKNVS----------EEAKDLI 236
                         250
                  ....*....|....*....
gi 1780598599 919 LKCTAIDPQERPCTNNVLQ 937
Cdd:cd05117   237 KRLLVVDPKKRLTAAEALN 255
LRR_RI cd00116
Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 ...
96-386 7.60e-09

Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).


Pssm-ID: 238064 [Multi-domain]  Cd Length: 319  Bit Score: 58.52  E-value: 7.60e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  96 LPFLQTINLSNNNLSGPIPHDIFT--TSSPSLRYLNLSNNnFSGSIPRGF---------LPNLYTLDLSNNMFTGE---I 161
Cdd:cd00116    22 LLCLQVLRLEGNTLGEEAAKALASalRPQPSLKELCLSLN-ETGRIPRGLqsllqgltkGCGLQELDLSDNALGPDgcgV 100
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 162 YNDIGVFSNLRVLDLGGNVLTGhvpgylgnlSRLEFL--TLASNQLtggvpvelgkmkNLKWIYLGYNNLSGEIPYQIGG 239
Cdd:cd00116   101 LESLLRSSSLQELKLNNNGLGD---------RGLRLLakGLKDLPP------------ALEKLVLGRNRLEGASCEALAK 159
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 240 LSslnhldlvynnlsgpipPSLGDLKKLEymfLYQNKLSGQIPPSIF----SLQNLISLDFSDNSL----SGEIPELVAQ 311
Cdd:cd00116   160 AL-----------------RANRDLKELN---LANNGIGDAGIRALAeglkANCNLEVLDLNNNGLtdegASALAETLAS 219
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 312 MQSLEILHLFSNNLTGKI-----PEGVTSLPRLKVLQLWSNR--------FSGGIPANLgkhnNLTVLDLSTNNLTGKLP 378
Cdd:cd00116   220 LKSLEVLNLGDNNLTDAGaaalaSALLSPNISLLTLSLSCNDitddgakdLAEVLAEKE----SLLELDLRGNKFGEEGA 295

                  ....*...
gi 1780598599 379 DTLCDSGH 386
Cdd:cd00116   296 QLLAESLL 303
STKc_IRAK4 cd14158
Catalytic domain of the Serine/Threonine kinase, Interleukin-1 Receptor Associated Kinase 4; ...
700-940 8.97e-09

Catalytic domain of the Serine/Threonine kinase, Interleukin-1 Receptor Associated Kinase 4; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. IRAKs are involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) signalling pathways, and are thus critical in regulating innate immune responses and inflammation. IRAKs contain an N-terminal Death domain (DD), a proST region (rich in serines, prolines, and threonines), a central kinase domain, and a C-terminal domain; IRAK-4 lacks the C-terminal domain. Vertebrates contain four IRAKs (IRAK-1, -2, -3 (or -M), and -4) that display distinct functions and patterns of expression and subcellular distribution, and can differentially mediate TLR signaling. IRAK4 plays a critical role in NFkB activation by its interaction with MyD88, which acts as a scaffold that enables IRAK4 to phosphorylate and activate IRAK1 and/or IRAK2. It also plays an important role in type I IFN production induced by TLR7/8/9. The IRAK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271060 [Multi-domain]  Cd Length: 288  Bit Score: 57.89  E-value: 8.97e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 700 LKDQNVLVDK--NGVHFVVKEVKKydSLPEMISDMRKLSdHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLS------ 771
Cdd:cd14158    36 INDKNVAVKKlaAMVDISTEDLTK--QFEQEIQVMAKCQ-HENLVELLGYSCDGPQLCLVYTYMPNGSLLDRLAclndtp 112
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 772 GLSWERRRKIMKGIVEALRFLHcrcSPAVVAGNLSPENIVIDVTDEPR-------------LCLGLPGLLCMDAAYMAPE 838
Cdd:cd14158   113 PLSWHMRCKIAQGTANGINYLH---ENNHIHRDIKSANILLDETFVPKisdfglarasekfSQTIMTERIVGTTAYMAPE 189
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 839 TREHkEMTSKSDIYGFGILLLHLLTG-----------KCSSSNEDIESGVNgslvkwARYSYSNCHIDTWidssidtsvh 907
Cdd:cd14158   190 ALRG-EITPKSDIFSFGVVLLEIITGlppvdenrdpqLLLDIKEEIEDEEK------TIEDYVDKKMGDW---------- 252
                         250       260       270
                  ....*....|....*....|....*....|....
gi 1780598599 908 QREIVHVM-NLALKCTAIDPQERPCTNNVLQALE 940
Cdd:cd14158   253 DSTSIEAMySVASQCLNDKKNRRPDIAKVQQLLQ 286
PLN03150 PLN03150
hypothetical protein; Provisional
366-449 4.31e-08

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 57.13  E-value: 4.31e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 366 LDLSTNNLTGKLPDTLCDSGHLTKLILFSNSLDSQIPPSLGMCQSLERVRLQNNGFSGKLPRGFTKLQLVNFLDLSNNNL 445
Cdd:PLN03150  423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502

                  ....
gi 1780598599 446 QGNI 449
Cdd:PLN03150  503 SGRV 506
STKc_MAPKKK cd06606
Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase ...
709-865 5.59e-08

Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270783 [Multi-domain]  Cd Length: 258  Bit Score: 54.83  E-value: 5.59e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 709 KNGVHFVVKEV-------KKYDSLPEMISDMRKLSdHKNILKIVATCRSETVAYLIHEDVEGKRLSQVL---SGLSWERR 778
Cdd:cd06606    23 DTGELMAVKEVelsgdseEELEALEREIRILSSLK-HPNIVRYLGTERTENTLNIFLEYVPGGSLASLLkkfGKLPEPVV 101
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 779 RKIMKGIVEALRFLHCRCspaVVAGNLSPENIVIDVTDE---------PRLCLGLPGLLCMDAA----YMAPETREHKEM 845
Cdd:cd06606   102 RKYTRQILEGLEYLHSNG---IVHRDIKGANILVDSDGVvkladfgcaKRLAEIATGEGTKSLRgtpyWMAPEVIRGEGY 178
                         170       180
                  ....*....|....*....|
gi 1780598599 846 TSKSDIYGFGILLLHLLTGK 865
Cdd:cd06606   179 GRAADIWSLGCTVIEMATGK 198
PK_IRAK3 cd14160
Pseudokinase domain of Interleukin-1 Receptor Associated Kinase 3; The pseudokinase domain ...
773-940 5.59e-08

Pseudokinase domain of Interleukin-1 Receptor Associated Kinase 3; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. IRAKs are involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) signalling pathways, and are thus critical in regulating innate immune responses and inflammation. IRAKs contain an N-terminal Death domain (DD), a proST region (rich in serines, prolines, and threonines), a central kinase domain (a pseudokinase in the case of IRAK3), and a C-terminal domain; IRAK-4 lacks the C-terminal domain. Vertebrates contain four IRAKs (IRAK-1, -2, -3 (or -M), and -4) that display distinct functions and patterns of expression and subcellular distribution, and can differentially mediate TLR signaling. IRAK3 (or IRAK-M) is the only IRAK that does not show kinase activity. It is found only in monocytes and macrophages in humans, and functions as a negative regulator of TLR signaling including TLR-2 induced p38 activation. It also negatively regulates the alternative NFkB pathway in a TLR-2 specific manner. IRAK3 is downregulated in the monocytes of obese people, and is associated with high SOD2, a marker of mitochondrial oxidative stress. It is an important inhibitor of inflammation in association with obesity and metabolic syndrome. The IRAK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271062 [Multi-domain]  Cd Length: 276  Bit Score: 55.28  E-value: 5.59e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 773 LSWERRRKIMKGIVEALRFLHCRCSPAVVAGNLSPENIVIDVTDEPRL-----------CLGLPGLLCMDAA------YM 835
Cdd:cd14160    92 LSWHERINILIGIAKAIHYLHNSQPCTVICGNISSANILLDDQMQPKLtdfalahfrphLEDQSCTINMTTAlhkhlwYM 171
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 836 APETREHKEMTSKSDIYGFGILLLHLLTGkCSSSNEDIES----GVNGSLVKwarysysnchiDTWIDSSIdtSVHQREI 911
Cdd:cd14160   172 PEEYIRQGKLSVKTDVYSFGIVIMEVLTG-CKVVLDDPKHlqlrDLLHELME-----------KRGLDSCL--SFLDLKF 237
                         170       180       190
                  ....*....|....*....|....*....|....*..
gi 1780598599 912 VH--------VMNLALKCTAIDPQERPCTNNVLQALE 940
Cdd:cd14160   238 PPcprnfsakLFRLAGRCTATKAKLRPDMDEVLQRLE 274
STKc_PhKG cd14093
Catalytic domain of the Serine/Threonine Kinase, Phosphorylase kinase Gamma subunit; STKs ...
729-813 5.65e-08

Catalytic domain of the Serine/Threonine Kinase, Phosphorylase kinase Gamma subunit; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Phosphorylase kinase (PhK) catalyzes the phosphorylation of inactive phosphorylase b to form the active phosphorylase a. It coordinates hormonal, metabolic, and neuronal signals to initiate the breakdown of glycogen stores, which enables the maintenance of blood-glucose homeostasis during fasting, and is also used as a source of energy for muscle contraction. PhK is one of the largest and most complex protein kinases, composed of a heterotetramer containing four molecules each of four subunit types: one catalytic (gamma) and three regulatory (alpha, beta, and delta). Each subunit has tissue-specific isoforms or splice variants. Vertebrates contain two isoforms of the gamma subunit (gamma 1 and gamma 2). The gamma subunit, when isolated, is constitutively active and does not require phosphorylation of the A-loop for activity. The regulatory subunits restrain this kinase activity until signals are received to relieve this inhibition. For example, the kinase is activated in response to hormonal stimulation, after autophosphorylation or phosphorylation by cAMP-dependent kinase of the alpha and beta subunits. The high-affinity binding of ADP to the beta subunit also stimulates kinase activity, whereas calcium relieves inhibition by binding to the delta (calmodulin) subunit. The PhKG subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270995 [Multi-domain]  Cd Length: 272  Bit Score: 55.05  E-value: 5.65e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 729 ISDMRKLSDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG---LSWERRRKIMKGIVEALRFLHCRCspaVVAGNL 805
Cdd:cd14093    59 IEILRQVSGHPNIIELHDVFESPTFIFLVFELCRKGELFDYLTEvvtLSEKKTRRIMRQLFEAVEFLHSLN---IVHRDL 135

                  ....*...
gi 1780598599 806 SPENIVID 813
Cdd:cd14093   136 KPENILLD 143
PPP1R42 cd21340
protein phosphatase 1 regulatory subunit 42; Protein phosphatase 1 regulatory subunit 42 ...
121-318 7.10e-08

protein phosphatase 1 regulatory subunit 42; Protein phosphatase 1 regulatory subunit 42 (PPP1R42), also known as leucine-rich repeat-containing protein 67 (lrrc67) or testis leucine-rich repeat (TLRR) protein, plays a role in centrosome separation. PPP1R42 has been shown to interact with the well-conserved signaling protein phosphatase-1 (PP1) and thereby increasing PP1's activity, which counters centrosome separation. Inhibition of PPP1R42 expression increases the number of centrosomes per cell while its depletion reduces the activity of PP1 leading to activation of NEK2, the kinase responsible for phosphorylation of centrosomal linker proteins promoting centrosome separation.


Pssm-ID: 411060 [Multi-domain]  Cd Length: 220  Bit Score: 54.02  E-value: 7.10e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 121 SSPSLRYLNLSNNNFSgSIPR-GFLPNLYTLDLSNNMFTgEIYNdIGVFSNLRVLDLGGN---VLTGhvpgyLGNLSRLE 196
Cdd:cd21340    22 LCKNLKVLYLYDNKIT-KIENlEFLTNLTHLYLQNNQIE-KIEN-LENLVNLKKLYLGGNrisVVEG-----LENLTNLE 93
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 197 FLTLASNQLTGGVPVELGkmknlkwiylgynnlsgeiPYQIGGLS-SLNHLDLVYNNLSGPIPpsLGDLKKLEYMFLYQN 275
Cdd:cd21340    94 ELHIENQRLPPGEKLTFD-------------------PRSLAALSnSLRVLNISGNNIDSLEP--LAPLRNLEQLDASNN 152
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*...
gi 1780598599 276 KLS--GQIPPSIFSLQNLISLDFSDNSLSGEI---PELVAQMQSLEIL 318
Cdd:cd21340   153 QISdlEELLDLLSSWPSLRELDLTGNPVCKKPkyrDKIILASKSLEVL 200
PKc_LIMK_like cd14065
Catalytic domain of the LIM domain kinase-like protein kinases; PKs catalyze the transfer of ...
715-862 7.45e-08

Catalytic domain of the LIM domain kinase-like protein kinases; PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. Members of this subfamily include LIMK, Testicular or testis-specific protein kinase (TESK), and similar proteins. LIMKs are characterized as serine/threonine kinases (STKs) while TESKs are dual-specificity protein kinases. Both LIMK and TESK phosphorylate and inactivate cofilin, an actin depolymerizing factor, to induce the reorganization of the actin cytoskeleton. They are implicated in many cellular functions including cell spreading, motility, morphogenesis, meiosis, mitosis, and spermatogenesis. The LIMK-like subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270967 [Multi-domain]  Cd Length: 252  Bit Score: 54.42  E-value: 7.45e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 715 VVKEVKKYD---SLPEMISDMRKLSdHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG----LSWERRRKIMKGIVE 787
Cdd:cd14065    22 VMKELKRFDeqrSFLKEVKLMRRLS-HPNILRFIGVCVKDNKLNFITEYVNGGTLEELLKSmdeqLPWSQRVSLAKDIAS 100
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 788 ALRFLHcrcSPAVVAGNLSPEN------------IVID------VTDEPRLCLGLPGLLCM--DAAYMAPETREHKEMTS 847
Cdd:cd14065   101 GMAYLH---SKNIIHRDLNSKNclvreanrgrnaVVADfglareMPDEKTKKPDRKKRLTVvgSPYWMAPEMLRGESYDE 177
                         170
                  ....*....|....*
gi 1780598599 848 KSDIYGFGILLLHLL 862
Cdd:cd14065   178 KVDVFSFGIVLCEII 192
PK_NRBP1_like cd13984
Pseudokinase domain of Nuclear Receptor Binding Protein 1 and similar proteins; The ...
764-936 8.79e-08

Pseudokinase domain of Nuclear Receptor Binding Protein 1 and similar proteins; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity and/or ATP binding. This subfamily is composed of NRBP1, also called MLF1-adaptor molecule (MADM), and MADML. NRBP1 was originally named based on the presence of nuclear binding and localization motifs prior to functional analyses. It is expressed ubiquitously and is found to localize in the cytoplasm, not the nucleus. NRBP1 is an adaptor protein that interacts with myeloid leukemia factor 1 (MLF1), an oncogene that enhances myeloid development of hematopoietic cells. It also interacts with the small GTPase Rac3. NRBP1 may also be involved in Golgi to ER trafficking. MADML (for MADM-Like) has been shown to be expressed throughout development in Xenopus laevis with highest expression found in the developing lens and retina. The NRBP1-like subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270886 [Multi-domain]  Cd Length: 256  Bit Score: 54.47  E-value: 8.79e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 764 KRLSQVLSGLSWERrrkIMKGIVEALRFLHCrCSPAVVAGNLSPENIVID----------VTDEPRLCLGLPGLLCMDAA 833
Cdd:cd13984    94 KKNHKTMNEKSWKR---WCTQILSALSYLHS-CDPPIIHGNLTCDTIFIQhnglikigsvAPDAIHNHVKTCREEHRNLH 169
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 834 YMAPETREHKEMTSKSDIYGFGI-------LLLHLLTGKCSSSNEDIESGVNGslvkwarysysnchidtwIDSSIdtsv 906
Cdd:cd13984   170 FFAPEYGYLEDVTTAVDIYSFGMcalemaaLEIQSNGEKVSANEEAIIRAIFS------------------LEDPL---- 227
                         170       180       190
                  ....*....|....*....|....*....|
gi 1780598599 907 hQREIVHvmnlalKCTAIDPQERPCTNNVL 936
Cdd:cd13984   228 -QKDFIR------KCLSVAPQDRPSARDLL 250
STKc_IRAK1 cd14159
Catalytic domain of the Serine/Threonine kinase, Interleukin-1 Receptor Associated Kinase 1; ...
714-865 1.04e-07

Catalytic domain of the Serine/Threonine kinase, Interleukin-1 Receptor Associated Kinase 1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. IRAKs are involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) signalling pathways, and are thus critical in regulating innate immune responses and inflammation. IRAKs contain an N-terminal Death domain (DD), a proST region (rich in serines, prolines, and threonines), a central kinase domain, and a C-terminal domain; IRAK-4 lacks the C-terminal domain. Vertebrates contain four IRAKs (IRAK-1, -2, -3 (or -M), and -4) that display distinct functions and patterns of expression and subcellular distribution, and can differentially mediate TLR signaling. IRAK1 plays a role in the activation of IRF3/7, STAT, and NFkB. It mediates IL-6 and IFN-gamma responses following IL-1 and IL-18 stimulation, respectively. It also plays an essential role in IFN-alpha induction downstream of TLR7 and TLR9. The IRAK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271061 [Multi-domain]  Cd Length: 296  Bit Score: 54.83  E-value: 1.04e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 714 FVVKEVKKYDSLP------EMISDMRKLSD--HKNILKIVATCRSETV-----AYLIHEDVEGKRLSQVLS-GLSWERRR 779
Cdd:cd14159    19 YAVKRLKEDSELDwsvvknSFLTEVEKLSRfrHPNIVDLAGYSAQQGNycliyVYLPNGSLEDRLHCQVSCpCLSWSQRL 98
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 780 KIMKGIVEALRFLHcRCSPAVVAGNLSPENIVIDVTDEPRL----------CLGLPGLLCMDA---------AYMAPETR 840
Cdd:cd14159    99 HVLLGTARAIQYLH-SDSPSLIHGDVKSSNILLDAALNPKLgdfglarfsrRPKQPGMSSTLArtqtvrgtlAYLPEEYV 177
                         170       180
                  ....*....|....*....|....*
gi 1780598599 841 EHKEMTSKSDIYGFGILLLHLLTGK 865
Cdd:cd14159   178 KTGTLSVEIDVYSFGVVLLELLTGR 202
PLN03150 PLN03150
hypothetical protein; Provisional
351-426 1.30e-07

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 55.59  E-value: 1.30e-07
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1780598599 351 GGIPANLGKHNNLTVLDLSTNNLTGKLPDTLCDSGHLTKLILFSNSLDSQIPPSLGMCQSLERVRLQNNGFSGKLP 426
Cdd:PLN03150  432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
LRR_8 pfam13855
Leucine rich repeat;
479-538 1.41e-07

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 49.06  E-value: 1.41e-07
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 479 RLKKLDLSRNKISGVVPQGLMTFPEIMDLDLSENEITGVIPRELSSCKNLVNLDLSHNNF 538
Cdd:pfam13855   2 NLRSLDLSNNRLTSLDDGAFKGLSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
PK_GC cd13992
Pseudokinase domain of membrane Guanylate Cyclase receptors; The pseudokinase domain shows ...
727-930 2.14e-07

Pseudokinase domain of membrane Guanylate Cyclase receptors; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. Membrane (or particulate) GCs consist of an extracellular ligand-binding domain, a single transmembrane region, and an intracellular tail that contains a PK-like domain, an amphiphatic region and a catalytic GC domain that catalyzes the conversion of GTP into cGMP and pyrophosphate. Membrane GCs act as receptors that transduce an extracellular signal to the intracellular production of cGMP, which has been implicated in many processes including cell proliferation, phototransduction, and muscle contractility, through its downstream effectors such as PKG. The PK-like domain of GCs lack a critical aspartate involved in ATP binding and does not exhibit kinase activity. It functions as a negative regulator of the catalytic GC domain and may also act as a docking site for interacting proteins such as GC-activating proteins. The GC subfamily is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270894 [Multi-domain]  Cd Length: 268  Bit Score: 53.55  E-value: 2.14e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 727 EMISDMRKLsDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLS----GLSWERRRKIMKGIVEALRFLHCrcSPAVVA 802
Cdd:cd13992    45 QELNQLKEL-VHDNLNKFIGICINPPNIAVVTEYCTRGSLQDVLLnreiKMDWMFKSSFIKDIVKGMNYLHS--SSIGYH 121
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 803 GNLSPENIVID------VTD----EPRLCLGLPGLLCM----DAAYMAPE----TREHKEMTSKSDIYGFGILLLHLLTG 864
Cdd:cd13992   122 GRLKSSNCLVDsrwvvkLTDfglrNLLEEQTNHQLDEDaqhkKLLWTAPEllrgSLLEVRGTQKGDVYSFAIILYEILFR 201
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1780598599 865 KCSSSNEDIESGVngslvkwarYSYSNCHIDTWIDSSIDTSVHQREIvhVMNLALKCTAIDPQERP 930
Cdd:cd13992   202 SDPFALEREVAIV---------EKVISGGNKPFRPELAVLLDEFPPR--LVLLVKQCWAENPEKRP 256
STKc_RIP4_like cd14025
Catalytic domain of the Serine/Threonine kinases, Receptor Interacting Protein 4 and similar ...
720-940 3.76e-07

Catalytic domain of the Serine/Threonine kinases, Receptor Interacting Protein 4 and similar proteins; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed of RIP4, ankyrin (ANK) repeat and kinase domain containing 1 (ANKK1), and similar proteins, all of which harbor C-terminal ANK repeats. RIP4, also called Protein Kinase C-associated kinase (PKK), regulates keratinocyte differentiation and cutaneous inflammation. It activates NF-kappaB and is important in the survival of diffuse large B-cell lymphoma cells. The ANKK1 protein, also called PKK2, has not been studied extensively. The ANKK1 gene, located less than 10kb downstream of the D2 dopamine receptor (DRD2) locus, is altered in the Taq1 A1 polymorphism, which is related to a reduced DRD2 binding affinity and consequently, to mental disorders. The RIP4-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270927 [Multi-domain]  Cd Length: 267  Bit Score: 52.50  E-value: 3.76e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 720 KKYDSLPEMISDMRKLSdHKNILKIVATCrSETVAyLIHEDVEGKRLSQVLSG--LSWERRRKIMKGIVEALRFLHCrCS 797
Cdd:cd14025    37 SERMELLEEAKKMEMAK-FRHILPVYGIC-SEPVG-LVMEYMETGSLEKLLASepLPWELRFRIIHETAVGMNFLHC-MK 112
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 798 PAVVAGNLSPENIVID------VTD---EPRLCLGLPGLLCMDA-----AYMAPETREHKEMTS--KSDIYGFGILLLHL 861
Cdd:cd14025   113 PPLLHLDLKPANILLDahyhvkISDfglAKWNGLSHSHDLSRDGlrgtiAYLPPERFKEKNRCPdtKHDVYSFAIVIWGI 192
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 862 LTGKCSSSNEDIESGVNGSLVKWARYSYsnchidtwidsSIDTSVHQREIVHVMNLALKCTAIDPQERPC-------TNN 934
Cdd:cd14025   193 LTQKKPFAGENNILHIMVKVVKGHRPSL-----------SPIPRQRPSECQQMICLMKRCWDQDPRKRPTfqditseTEN 261

                  ....*.
gi 1780598599 935 VLQALE 940
Cdd:cd14025   262 LLSLLE 267
PTKc cd00192
Catalytic domain of Protein Tyrosine Kinases; PTKs catalyze the transfer of the ...
716-858 5.37e-07

Catalytic domain of Protein Tyrosine Kinases; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers.The PTK family is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270623 [Multi-domain]  Cd Length: 262  Bit Score: 52.16  E-value: 5.37e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 716 VKEVKKYDSLPEM------ISDMRKLsDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVL------------SGLSWER 777
Cdd:cd00192    28 VKTLKEDASESERkdflkeARVMKKL-GHPNVVRLLGVCTEEEPLYLVMEYMEGGDLLDFLrksrpvfpspepSTLSLKD 106
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 778 RRKIMKGIVEALRFLHcrcSPAVVAGNLSPENIVID------VTD-------EPRLCLGLPGLLCMDAAYMAPETREHKE 844
Cdd:cd00192   107 LLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGedlvvkISDfglsrdiYDDDYYRKKTGGKLPIRWMAPESLKDGI 183
                         170
                  ....*....|....
gi 1780598599 845 MTSKSDIYGFGILL 858
Cdd:cd00192   184 FTSKSDVWSFGVLL 197
STKc_ATG1_ULK_like cd14009
Catalytic domain of the Serine/Threonine kinases, Autophagy-related protein 1 and Unc-51-like ...
709-865 9.97e-07

Catalytic domain of the Serine/Threonine kinases, Autophagy-related protein 1 and Unc-51-like kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily includes yeast ATG1 and metazoan homologs including vertebrate ULK1-3. The ATG1/ULK complex is conserved from yeast to humans and it plays a critical role in the initiation of autophagy, the intracellular system that leads to the lysosomal degradation of cellular components and their recycling into basic metabolic units. It is involved in nutrient sensing and signaling, the assembly of autophagy factors and the execution of autophagy. In metazoans, ATG1 homologs display additional functions. Unc-51 and ULKs have been implicated in neuronal and axonal development. The ATG1/ULK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270911 [Multi-domain]  Cd Length: 251  Bit Score: 51.07  E-value: 9.97e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 709 KNGVHFVVKEV-------KKYDSLPEMISDMRKLsDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVL---SGLSWERR 778
Cdd:cd14009    16 QTGEVVAIKEIsrkklnkKLQENLESEIAILKSI-KHPNIVRLYDVQKTEDFIYLVLEYCAGGDLSQYIrkrGRLPEAVA 94
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 779 RKIMKGIVEALRFLHCRcspAVVAGNLSPENIVIDVTDEprlclglpgllcmDAA------------------------- 833
Cdd:cd14009    95 RHFMQQLASGLKFLRSK---NIIHRDLKPQNLLLSTSGD-------------DPVlkiadfgfarslqpasmaetlcgsp 158
                         170       180       190
                  ....*....|....*....|....*....|...
gi 1780598599 834 -YMAPETREHKEMTSKSDIYGFGILLLHLLTGK 865
Cdd:cd14009   159 lYMAPEILQFQKYDAKADLWSVGAILFEMLVGK 191
PK_SCY1_like cd14011
Pseudokinase domain of Scy1-like proteins; The pseudokinase domain shows similarity to protein ...
785-865 1.14e-06

Pseudokinase domain of Scy1-like proteins; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. This subfamily is composed of the catalytically inactive kinases with similarity to yeast Scy1. It includes four mammalian proteins called SCY1-like protein 1 (SCYL1), SCYL2, SCYL3, as well as Testis-EXpressed protein 14 (TEX14). SCYL1 binds to and co-localizes with the membrane trafficking coatomer I (COPI) complex, and regulates COPI-mediated vesicle trafficking. Null mutations in the SCYL1 gene are responsible for the pathology in mdf (muscle-deficient) mice which display progressive motor neuropathy. SCYL2, also called coated vesicle-associated kinase of 104 kDa (CVAK104), is involved in the trafficking of clathrin-coated vesicles. It also binds the HIV-1 accessory protein Vpu and acts as a regulatory factor that promotes the dephosphorylation of Vpu, facilitating the restriction of HIV-1 release. SCYL3, also called ezrin-binding protein PACE-1, may be involved in regulating cell adhesion and migration. TEX14 is required for spermatogenesis and male fertility. It localizes to kinetochores (KT) during mitosis and is a target of the mitotic kinase PLK1. It regulates the maturation of the outer KT and the KT-microtubule attachment. The SCY1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270913 [Multi-domain]  Cd Length: 287  Bit Score: 51.17  E-value: 1.14e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 785 IVEALRFLHCRCSpaVVAGNLSPENIVID------------------VTDEPRLCLGLPGLLCMDAA----YMAPETREH 842
Cdd:cd14011   123 ISEALSFLHNDVK--LVHGNICPESVVINsngewklagfdfcisseqATDQFPYFREYDPNLPPLAQpnlnYLAPEYILS 200
                          90       100
                  ....*....|....*....|....
gi 1780598599 843 KEMTSKSDIYGFGILLLHLL-TGK 865
Cdd:cd14011   201 KTCDPASDMFSLGVLIYAIYnKGK 224
PPP1R42 cd21340
protein phosphatase 1 regulatory subunit 42; Protein phosphatase 1 regulatory subunit 42 ...
240-419 1.94e-06

protein phosphatase 1 regulatory subunit 42; Protein phosphatase 1 regulatory subunit 42 (PPP1R42), also known as leucine-rich repeat-containing protein 67 (lrrc67) or testis leucine-rich repeat (TLRR) protein, plays a role in centrosome separation. PPP1R42 has been shown to interact with the well-conserved signaling protein phosphatase-1 (PP1) and thereby increasing PP1's activity, which counters centrosome separation. Inhibition of PPP1R42 expression increases the number of centrosomes per cell while its depletion reduces the activity of PP1 leading to activation of NEK2, the kinase responsible for phosphorylation of centrosomal linker proteins promoting centrosome separation.


Pssm-ID: 411060 [Multi-domain]  Cd Length: 220  Bit Score: 49.78  E-value: 1.94e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 240 LSSLNHLDLVYNNLSgpippSLGDL---KKLEYMFLYQNKLSgQIPpSIFSLQNLISLDFSDNSLSgEIPELVAqMQSLE 316
Cdd:cd21340     1 LKRITHLYLNDKNIT-----KIDNLslcKNLKVLYLYDNKIT-KIE-NLEFLTNLTHLYLQNNQIE-KIENLEN-LVNLK 71
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 317 ILHLFSNNLTgKIpEGVTSLPRLKVLQLWSNR--------FSGGIPANLGkhNNLTVLDLSTNNLTGklPDTLCDSGHLT 388
Cdd:cd21340    72 KLYLGGNRIS-VV-EGLENLTNLEELHIENQRlppgekltFDPRSLAALS--NSLRVLNISGNNIDS--LEPLAPLRNLE 145
                         170       180       190
                  ....*....|....*....|....*....|...
gi 1780598599 389 KLILFSNSLDS--QIPPSLGMCQSLERVRLQNN 419
Cdd:cd21340   146 QLDASNNQISDleELLDLLSSWPSLRELDLTGN 178
PK_eIF2AK_GCN2_rpt1 cd14012
Pseudokinase domain, repeat 1, of eukaryotic translation Initiation Factor 2-Alpha Kinase 4 or ...
734-865 3.02e-06

Pseudokinase domain, repeat 1, of eukaryotic translation Initiation Factor 2-Alpha Kinase 4 or General Control Non-derepressible-2; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. EIF2AKs phosphorylate the alpha subunit of eIF-2, resulting in the overall downregulation of protein synthesis. eIF-2 phosphorylation is induced in response to cellular stresses including virus infection, heat shock, nutrient deficiency, and the accummulation of unfolded proteins, among others. There are four distinct kinases that phosphorylate eIF-2 and control protein synthesis under different stress conditions: GCN2, protein kinase regulated by RNA (PKR), heme-regulated inhibitor kinase (HRI), and PKR-like endoplasmic reticulum kinase (PERK). GCN2 is activated by amino acid or serum starvation and UV irradiation. It induces GCN4, a transcriptional activator of amino acid biosynthetic genes, leading to increased production of amino acids under amino acid-deficient conditions. In serum-starved cells, GCN2 activation induces translation of the stress-responsive transcription factor ATF4, while under UV stress, GCN2 triggers transcriptional rescue via NF-kappaB signaling. GCN2 contains an N-terminal RWD, a degenerate kinase-like (repeat 1), the catalytic kinase (repeat 2), a histidyl-tRNA synthetase (HisRS)-like, and a C-terminal ribosome-binding and dimerization (RB/DD) domains. The degenerate pseudokinase domain of GCN2 may function as a regulatory domain. The GCN2 subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270914 [Multi-domain]  Cd Length: 254  Bit Score: 49.67  E-value: 3.02e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 734 KLSdHKNILKIVATCRSET------VAYLIHEDVEGKRLSQVLS---GLSWERRRKIMKGIVEALRFLHCRcspAVVAGN 804
Cdd:cd14012    54 KLR-HPNLVSYLAFSIERRgrsdgwKVYLLTEYAPGGSLSELLDsvgSVPLDTARRWTLQLLEALEYLHRN---GVVHKS 129
                          90       100       110       120       130       140       150
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1780598599 805 LSPENIVID---------VTD-----EPRLCLGLPGLLCM-DAAYMAPE-TREHKEMTSKSDIYGFGILLLHLLTGK 865
Cdd:cd14012   130 LHAGNVLLDrdagtgivkLTDyslgkTLLDMCSRGSLDEFkQTYWLPPElAQGSKSPTRKTDVWDLGLLFLQMLFGL 206
STKc_MLK3 cd14147
Catalytic domain of the Serine/Threonine Kinase, Mixed Lineage Kinase 3; STKs catalyze the ...
738-940 4.90e-06

Catalytic domain of the Serine/Threonine Kinase, Mixed Lineage Kinase 3; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MLK3 is a mitogen-activated protein kinase kinase kinases (MAP3K, MKKK, MAPKKK), which phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MLK3 activates multiple MAPK pathways and plays a role in apoptosis, proliferation, migration, and differentiation, depending on the cellular context. It is highly expressed in breast cancer cells and its signaling through c-Jun N-terminal kinase has been implicated in the migration, invasion, and malignancy of cancer cells. MLK3 also functions as a negative regulator of Inhibitor of Nuclear Factor-KappaB Kinase (IKK) and consequently, it also impacts inflammation and immunity. Mammals have four MLKs, mostly conserved in vertebrates, which contain an SH3 domain, a catalytic kinase domain, a leucine zipper, a proline-rich region, and a CRIB domain that mediates binding to GTP-bound Cdc42 and Rac. MLKs play roles in immunity and inflammation, as well as in cell death, proliferation, and cell cycle regulation.The MLK3 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271049 [Multi-domain]  Cd Length: 267  Bit Score: 49.26  E-value: 4.90e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 738 HKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG--------LSWERRrkimkgIVEALRFLHCRCSPAVVAGNLSPEN 809
Cdd:cd14147    61 HPNIIALKAVCLEEPNLCLVMEYAAGGPLSRALAGrrvpphvlVNWAVQ------IARGMHYLHCEALVPVIHRDLKSNN 134
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 810 IV--------------IDVTDEPRLCLGLPGLLCMDA---AYMAPETREHKEMTSKSDIYGFGILLLHLLTGkcsssnED 872
Cdd:cd14147   135 ILllqpienddmehktLKITDFGLAREWHKTTQMSAAgtyAWMAPEVIKASTFSKGSDVWSFGVLLWELLTG------EV 208
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1780598599 873 IESGVNGSLVKwarYSYSNCHIDTWIDSSIDTSVHQreivhvmnLALKCTAIDPQERPCTNNVLQALE 940
Cdd:cd14147   209 PYRGIDCLAVA---YGVAVNKLTLPIPSTCPEPFAQ--------LMADCWAQDPHRRPDFASILQQLE 265
PK_GC-C cd14044
Pseudokinase domain of the membrane Guanylate Cyclase receptor, GC-C; The pseudokinase domain ...
737-930 5.73e-06

Pseudokinase domain of the membrane Guanylate Cyclase receptor, GC-C; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity and/or ATP binding. GC-C binds and is activated by the intestinal hormones, guanylin (GN) and uroguanylin (UGN), which are secreted after salty meals to inhibit sodium absorption and induce the secretion of chloride, bicarbonate, and water. GN and UGN are also present in the kidney, where they induce increased salt and water secretion. This prevents the development of hypernatremia and hypervolemia after ingestion of high amounts of salt. Membrane (or particulate) GCs consist of an extracellular ligand-binding domain, a single transmembrane region, and an intracellular tail that contains a PK-like domain, an amphiphatic region and a catalytic GC domain that catalyzes the conversion of GTP into cGMP and pyrophosphate. Membrane GCs act as receptors that transduce an extracellular signal to the intracellular production of cGMP, which has been implicated in many processes including cell proliferation, phototransduction, and muscle contractility, through its downstream effectors such as PKG. The PK-like domain of GCs functions as a negative regulator of the catalytic GC domain and may also act as a docking site for interacting proteins such as GC-activating proteins. The GC-C subfamily is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270946 [Multi-domain]  Cd Length: 271  Bit Score: 49.11  E-value: 5.73e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 737 DHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG---------LSWERRRKIMKGIVEALRFLHCrcSPAVVAGNLSP 807
Cdd:cd14044    61 DYYNLTKFYGTVKLDTMIFGVIEYCERGSLRDVLNDkisypdgtfMDWEFKISVMYDIAKGMSYLHS--SKTEVHGRLKS 138
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 808 ENIVID------VTD-------EPRLCLglpgllcmdaaYMAPETREHKEMTSKSDIYGFGILLLHLL-------TGKCS 867
Cdd:cd14044   139 TNCVVDsrmvvkITDfgcnsilPPSKDL-----------WTAPEHLRQAGTSQKGDVYSYGIIAQEIIlrketfyTAACS 207
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1780598599 868 SSNEDIESGVNGSLVKWARysysnchidtwIDSSIDTsVHQREIvHVMNLALKCTAIDPQERP 930
Cdd:cd14044   208 DRKEKIYRVQNPKGMKPFR-----------PDLNLES-AGERER-EVYGLVKNCWEEDPEKRP 257
STKc_Mnk1 cd14174
Catalytic domain of the Serine/Threonine kinase, Mitogen-activated protein kinase ...
701-864 5.77e-06

Catalytic domain of the Serine/Threonine kinase, Mitogen-activated protein kinase signal-integrating kinase 1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MAPK signal-integrating kinases (Mnks) are MAPK-activated protein kinases and is comprised by a group of four proteins, produced by alternative splicing from two genes (Mnk1 and Mnk2). The isoforms of Mnk1 (1a/1b) and Mnk2 (2a/2b) differ at their C-termini, with the a-form having a longer C-terminus containing a MAPK-binding region. All Mnks contain a catalytic kinase domain and a polybasic region at the N-terminus which binds importin and the eukaryotic initiation factor eIF4G. The best characterized Mnk substrate is eIF4G, whose phosphorylation may promote the export of certain mRNAs from the nucleus. Mnk also phosphorylate substrates that bind to AU-rich elements that regulate mRNA stability and translation. Mnks have also been implicated in tyrosine kinase receptor signaling, inflammation, and cell prolieration or survival. The Mnk subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271076 [Multi-domain]  Cd Length: 289  Bit Score: 49.26  E-value: 5.77e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 701 KDQNVLVDKNGVHFVVKEVKK-----YDSLPEMISDMRKLSDHKNILKIVATCRSETVAYLIHEDVEGKR-LSQVLSGLS 774
Cdd:cd14174    17 KVQGCVSLQNGKEYAVKIIEKnaghsRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLRGGSiLAHIQKRKH 96
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 775 WERRR--KIMKGIVEALRFLHCRcspAVVAGNLSPENIVIDVTDE--PRLCLGLPGLLCM-------------------D 831
Cdd:cd14174    97 FNEREasRVVRDIASALDFLHTK---GIAHRDLKPENILCESPDKvsPVKICDFDLGSGVklnsactpittpelttpcgS 173
                         170       180       190
                  ....*....|....*....|....*....|....*...
gi 1780598599 832 AAYMAPE-----TREHKEMTSKSDIYGFGILLLHLLTG 864
Cdd:cd14174   174 AEYMAPEvvevfTDEATFYDKRCDLWSLGVILYIMLSG 211
LRR_8 pfam13855
Leucine rich repeat;
99-157 5.90e-06

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 44.44  E-value: 5.90e-06
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1780598599  99 LQTINLSNNNLSGpIPHDIFTtSSPSLRYLNLSNNNFSGSIPRGF--LPNLYTLDLSNNMF 157
Cdd:pfam13855   3 LRSLDLSNNRLTS-LDDGAFK-GLSNLKVLDLSNNLLTTLSPGAFsgLPSLRYLDLSGNRL 61
PPP1R42 cd21340
protein phosphatase 1 regulatory subunit 42; Protein phosphatase 1 regulatory subunit 42 ...
69-179 5.99e-06

protein phosphatase 1 regulatory subunit 42; Protein phosphatase 1 regulatory subunit 42 (PPP1R42), also known as leucine-rich repeat-containing protein 67 (lrrc67) or testis leucine-rich repeat (TLRR) protein, plays a role in centrosome separation. PPP1R42 has been shown to interact with the well-conserved signaling protein phosphatase-1 (PP1) and thereby increasing PP1's activity, which counters centrosome separation. Inhibition of PPP1R42 expression increases the number of centrosomes per cell while its depletion reduces the activity of PP1 leading to activation of NEK2, the kinase responsible for phosphorylation of centrosomal linker proteins promoting centrosome separation.


Pssm-ID: 411060 [Multi-domain]  Cd Length: 220  Bit Score: 48.24  E-value: 5.99e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  69 NNISRVVSLDlsgknmsgqiltaatfRLPFLQTINLSNNNLSGPIP----HDIFTTSSPSLRYLNLSNNNFSGSIPRGFL 144
Cdd:cd21340    78 NRISVVEGLE----------------NLTNLEELHIENQRLPPGEKltfdPRSLAALSNSLRVLNISGNNIDSLEPLAPL 141
                          90       100       110
                  ....*....|....*....|....*....|....*..
gi 1780598599 145 PNLYTLDLSNNMFT--GEIYNDIGVFSNLRVLDLGGN 179
Cdd:cd21340   142 RNLEQLDASNNQISdlEELLDLLSSWPSLRELDLTGN 178
RNA1 COG5238
Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Translation, ...
99-340 1.18e-05

Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Translation, ribosomal structure and biogenesis];


Pssm-ID: 444072 [Multi-domain]  Cd Length: 434  Bit Score: 49.02  E-value: 1.18e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  99 LQTINLSNNNLSGPIPHDIFT--TSSPSLRYLNLSNNNFSGSIPRGF------LPNLYTLDLSNNMFTGE----IYNDIG 166
Cdd:COG5238   182 VETVYLGCNQIGDEGIEELAEalTQNTTVTTLWLKRNPIGDEGAEILaealkgNKSLTTLDLSNNQIGDEgviaLAEALK 261
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 167 VFSNLRVLDLGGNVLTghVPGYLGnlsrlefltLASNqltggvpveLGKMKNLKWIYLGYNNLSGE----IPYQIGGLSS 242
Cdd:COG5238   262 NNTTVETLYLSGNQIG--AEGAIA---------LAKA---------LQGNTTLTSLDLSVNRIGDEgaiaLAEGLQGNKT 321
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 243 LNHLDLVYNNLSG----PIPPSLGDLKKLEYMFLYQNKLSGQ----IPPSIFSLQNLISLDFSDNSLSGE-IPELVAQMQ 313
Cdd:COG5238   322 LHTLNLAYNGIGAqgaiALAKALQENTTLHSLDLSDNQIGDEgaiaLAKYLEGNTTLRELNLGKNNIGKQgAEALIDALQ 401
                         250       260       270
                  ....*....|....*....|....*....|
gi 1780598599 314 --SLEILHLFSNNLTGKIPEGVTS-LPRLK 340
Cdd:COG5238   402 tnRLHTLILDGNLIGAEAQQRLEQlLERIK 431
STKc_Aurora cd14007
Catalytic domain of the Serine/Threonine kinase, Aurora kinase; STKs catalyze the transfer of ...
737-866 1.21e-05

Catalytic domain of the Serine/Threonine kinase, Aurora kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Aurora kinases are key regulators of mitosis and are essential for the accurate and equal division of genomic material from parent to daughter cells. Yeast contains only one Aurora kinase while most higher eukaryotes have two. Vertebrates contain at least 2 Aurora kinases (A and B); mammals contains a third Aurora kinase gene (C). Aurora-A regulates cell cycle events from the late S-phase through the M-phase including centrosome maturation, mitotic entry, centrosome separation, spindle assembly, chromosome alignment, cytokinesis, and mitotic exit. Aurora-A activation depends on its autophosphorylation and binding to the microtubule-associated protein TPX2. Aurora-B is most active at the transition during metaphase to the end of mitosis. It is critical for accurate chromosomal segregation, cytokinesis, protein localization to the centrosome and kinetochore, correct microtubule-kinetochore attachments, and regulation of the mitotic checkpoint. Aurora-C is mainly expressed in meiotically dividing cells; it was originally discovered in mice as a testis-specific STK called Aie1. Both Aurora-B and -C are chromosomal passenger proteins that can form complexes with INCENP and survivin, and they may have redundant cellular functions. The Aurora subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270909 [Multi-domain]  Cd Length: 253  Bit Score: 47.85  E-value: 1.21e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 737 DHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG---LSWERRRKIMKGIVEALRFLHcrcSPAVVAGNLSPENIVID 813
Cdd:cd14007    58 RHPNILRLYGYFEDKKRIYLILEYAPNGELYKELKKqkrFDEKEAAKYIYQLALALDYLH---SKNIIHRDIKPENILLG 134
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1780598599 814 VTDE---------------PRLCLGLPgllcMDaaYMAPETREHKEMTSKSDIYGFGILLLHLLTGKC 866
Cdd:cd14007   135 SNGElkladfgwsvhapsnRRKTFCGT----LD--YLPPEMVEGKEYDYKVDIWSLGVLCYELLVGKP 196
STKc_Trio_C cd14113
C-terminal kinase domain of the Large Serine/Threonine Kinase and Rho Guanine Nucleotide ...
702-874 1.86e-05

C-terminal kinase domain of the Large Serine/Threonine Kinase and Rho Guanine Nucleotide Exchange Factor, Triple functional domain protein; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Triple functional domain protein (Trio), also called PTPRF-interacting protein, is a large multidomain protein containing a series of spectrin-like repeats, two each of RhoGEF and SH3 domains, an immunoglobulin-like (Ig) domain and a C-terminal kinase. Trio plays important roles in neuronal cell migration and axon guidance. It was originally identified as an interacting partner of the of the receptor-like tyrosine phosphatase (RPTP) LAR (leukocyte-antigen-related protein), a family of receptors that function in the signaling to the actin cytoskeleton during development. Trio functions as a GEF for Rac1, RhoG, and RhoA, and is involved in the regulation of lamellipodia formation, mediating Rac1-dependent cell spreading and migration. The Trio subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271015 [Multi-domain]  Cd Length: 263  Bit Score: 47.28  E-value: 1.86e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 702 DQNVLVDKNGVHFVVKEVKKYDSLPEMISDMRKLSdHKNILKIVATCRSETVAYLIHEDV-EGKRLSQVLS--GLSWERR 778
Cdd:cd14113    27 DQRGTKRAVATKFVNKKLMKRDQVTHELGVLQSLQ-HPQLVGLLDTFETPTSYILVLEMAdQGRLLDYVVRwgNLTEEKI 105
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 779 RKIMKGIVEALRFLH-CRcspaVVAGNLSPENIVIDVT------------DEPRLCLGLPGLLCM-DAAYMAPETREHKE 844
Cdd:cd14113   106 RFYLREILEALQYLHnCR----IAHLDLKPENILVDQSlskptikladfgDAVQLNTTYYIHQLLgSPEFAAPEIILGNP 181
                         170       180       190
                  ....*....|....*....|....*....|
gi 1780598599 845 MTSKSDIYGFGILLLHLLTGKCSSSNEDIE 874
Cdd:cd14113   182 VSLTSDLWSIGVLTYVLLSGVSPFLDESVE 211
PLN03150 PLN03150
hypothetical protein; Provisional
414-522 2.21e-05

hypothetical protein; Provisional


Pssm-ID: 178695 [Multi-domain]  Cd Length: 623  Bit Score: 48.27  E-value: 2.21e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 414 VRLQNNGFSGKLPRGFTKLQLVNFLDLSNNNLQGNINtwdmpqlemldlsvnkffgelPDFSRSKRLKKLDLSRNKISGV 493
Cdd:PLN03150  423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIP---------------------PSLGSITSLEVLDLSYNSFNGS 481
                          90       100
                  ....*....|....*....|....*....
gi 1780598599 494 VPQGLMTFPEIMDLDLSENEITGVIPREL 522
Cdd:PLN03150  482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
LRR_RI cd00116
Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 ...
335-584 2.21e-05

Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).


Pssm-ID: 238064 [Multi-domain]  Cd Length: 319  Bit Score: 47.74  E-value: 2.21e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 335 SLPRLKVLQLWSNRFSGG----IPANLGKHNNLTVLDLSTNNlTGKLPDTLCDSGHltklilfsnsldsqippSLGMCQS 410
Cdd:cd00116    21 KLLCLQVLRLEGNTLGEEaakaLASALRPQPSLKELCLSLNE-TGRIPRGLQSLLQ-----------------GLTKGCG 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 411 LERVRLQNNGFSGKLPRGFTKLQLVNFL---DLSNNNLQgnintwdmpqlemlDLSVNKFFGELPDfsRSKRLKKLDLSR 487
Cdd:cd00116    83 LQELDLSDNALGPDGCGVLESLLRSSSLqelKLNNNGLG--------------DRGLRLLAKGLKD--LPPALEKLVLGR 146
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 488 NKISGvvpqGLMT-----FPEIMDL---DLSENEITG----VIPRELSSCKNLVNLDLSHNNFTGEIPSSFAE----FQV 551
Cdd:cd00116   147 NRLEG----ASCEalakaLRANRDLkelNLANNGIGDagirALAEGLKANCNLEVLDLNNNGLTDEGASALAEtlasLKS 222
                         250       260       270
                  ....*....|....*....|....*....|....*...
gi 1780598599 552 LSDLDLSCNQLSGEI-----PKNLGNIESLVQVNISHN 584
Cdd:cd00116   223 LEVLNLGDNNLTDAGaaalaSALLSPNISLLTLSLSCN 260
STKc_IRAK2 cd14157
Catalytic domain of the Serine/Threonine kinase, Interleukin-1 Receptor Associated Kinase 2; ...
738-864 2.73e-05

Catalytic domain of the Serine/Threonine kinase, Interleukin-1 Receptor Associated Kinase 2; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. IRAKs are involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) signalling pathways, and are thus critical in regulating innate immune responses and inflammation. IRAKs contain an N-terminal Death domain (DD), a proST region (rich in serines, prolines, and threonines), a central kinase domain, and a C-terminal domain; IRAK-4 lacks the C-terminal domain. Vertebrates contain four IRAKs (IRAK-1, -2, -3 (or -M), and -4) that display distinct functions and patterns of expression and subcellular distribution, and can differentially mediate TLR signaling. IRAK2 plays a role in mediating NFkB activation by TLR3, TLR4, and TLR8. It is specifically targeted by the viral protein A52, which is important for virulence, to inhibit all IL-1/TLR pathways, indicating that IRAK2 has a predominant role in NFkB activation. It is redundant with IRAK1 in early signaling but is critical for late and sustained activation. The IRAK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271059 [Multi-domain]  Cd Length: 289  Bit Score: 47.14  E-value: 2.73e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 738 HKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG------LSWERRRKIMKGIVEALRFLHcrcSPAVVAGNLSPENIV 811
Cdd:cd14157    51 HPNILPLLGFCVESDCHCLIYPYMPNGSLQDRLQQqggshpLPWEQRLSISLGLLKAVQHLH---NFGILHGNIKSSNVL 127
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1780598599 812 IDVTDEPRLCLGLPGLLCMD----------------AAYMAPETREHKEMTSKSDIYGFGILLLHLLTG 864
Cdd:cd14157   128 LDGNLLPKLGHSGLRLCPVDkksvytmmktkvlqisLAYLPEDFVRHGQLTEKVDIFSCGVVLAEILTG 196
STKc_CaMKI_alpha cd14167
Catalytic domain of the Serine/Threonine kinase, Calcium/calmodulin-dependent protein kinase ...
721-937 3.09e-05

Catalytic domain of the Serine/Threonine kinase, Calcium/calmodulin-dependent protein kinase Type I alpha; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CaMKs are multifunctional calcium and calmodulin (CaM) stimulated STKs involved in cell cycle regulation. The CaMK family includes CaMKI, CaMKII, CaMKIV, and CaMK kinase (CaMKK). In vertebrates, there are four CaMKI proteins encoded by different genes (alpha, beta, gamma, and delta), each producing at least one variant. CaMKs contain an N-terminal catalytic domain and a C-terminal regulatory domain that harbors a CaM binding site. CaMKI proteins are monomeric and they play pivotal roles in the nervous system, including long-term potentiation, dendritic arborization, neurite outgrowth, and the formation of spines, synapses, and axons. In addition, they may be involved in osteoclast differentiation and bone resorption. The CaMKI-alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271069 [Multi-domain]  Cd Length: 263  Bit Score: 46.56  E-value: 3.09e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 721 KYDSLPEMISDMRKLSdHKNILKIVATCRSETVAYLIHEDVEGKRLSQ--VLSGLSWER-RRKIMKGIVEALRFLHcrcS 797
Cdd:cd14167    44 KETSIENEIAVLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDriVEKGFYTERdASKLIFQILDAVKYLH---D 119
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 798 PAVVAGNLSPENIVIDVTDEPRLCLGLP--------GLLCMDAA-----YMAPETREHKEMTSKSDIYGFGILLLHLLTG 864
Cdd:cd14167   120 MGIVHRDLKPENLLYYSLDEDSKIMISDfglskiegSGSVMSTAcgtpgYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 199
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1780598599 865 KCSSSNEDiESGVNGSLVKwARYSYSNCHIDTWIDSSIDTsvhqreIVHVMNLalkctaiDPQERPCTNNVLQ 937
Cdd:cd14167   200 YPPFYDEN-DAKLFEQILK-AEYEFDSPYWDDISDSAKDF------IQHLMEK-------DPEKRFTCEQALQ 257
STKc_PhKG1 cd14182
Catalytic domain of the Serine/Threonine Kinase, Phosphorylase kinase Gamma 1 subunit; STKs ...
729-864 3.17e-05

Catalytic domain of the Serine/Threonine Kinase, Phosphorylase kinase Gamma 1 subunit; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Phosphorylase kinase (PhK) catalyzes the phosphorylation of inactive phosphorylase b to form the active phosphorylase a. It coordinates hormonal, metabolic, and neuronal signals to initiate the breakdown of glycogen stores, which enables the maintenance of blood-glucose homeostasis during fasting, and is also used as a source of energy for muscle contraction. PhK is one of the largest and most complex protein kinases, composed of a heterotetramer containing four molecules each of four subunit types: one catalytic (gamma) and three regulatory (alpha, beta, and delta). The gamma 1 subunit (PhKG1) is also referred to as the muscle gamma isoform. The gamma subunit, when isolated, is constitutively active and does not require phosphorylation of the A-loop for activity. The regulatory subunits restrain this kinase activity until signals are received to relieve this inhibition. For example, the kinase is activated in response to hormonal stimulation, after autophosphorylation or phosphorylation by cAMP-dependent kinase of the alpha and beta subunits. The high-affinity binding of ADP to the beta subunit also stimulates kinase activity, whereas calcium relieves inhibition by binding to the delta (calmodulin) subunit. The PhKG1 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271084 [Multi-domain]  Cd Length: 276  Bit Score: 46.83  E-value: 3.17e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 729 ISDMRKLSDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLS---GLSWERRRKIMKGIVEALRFLHcrcSPAVVAGNL 805
Cdd:cd14182    60 IDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTekvTLSEKETRKIMRALLEVICALH---KLNIVHRDL 136
                          90       100       110       120       130       140       150
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1780598599 806 SPENIVID------VTDEPRLCLGLPGLLCMDA----AYMAPETRE------HKEMTSKSDIYGFGILLLHLLTG 864
Cdd:cd14182   137 KPENILLDddmnikLTDFGFSCQLDPGEKLREVcgtpGYLAPEIIEcsmddnHPGYGKEVDMWSTGVIMYTLLAG 211
APH_ChoK_like cd05120
Aminoglycoside 3'-phosphotransferase and Choline Kinase family; This family is composed of APH, ...
732-817 3.91e-05

Aminoglycoside 3'-phosphotransferase and Choline Kinase family; This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K).


Pssm-ID: 270690 [Multi-domain]  Cd Length: 158  Bit Score: 44.99  E-value: 3.91e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 732 MRKLSDHKNIL--KIVATCRSETVAYLIHEDVEGKRLSQVLSGLSWERRRKIMKGIVEALRFLHCRCSPAVVAGNLSPEN 809
Cdd:cd05120    43 LQLLAGKLSLPvpKVYGFGESDGWEYLLMERIEGETLSEVWPRLSEEEKEKIADQLAEILAALHRIDSSVLTHGDLHPGN 122

                  ....*...
gi 1780598599 810 IVIDVTDE 817
Cdd:cd05120   123 ILVKPDGK 130
PKc_LIMK_like_unk cd14156
Catalytic domain of an unknown subfamily of LIM domain kinase-like protein kinases; PKs ...
729-940 4.01e-05

Catalytic domain of an unknown subfamily of LIM domain kinase-like protein kinases; PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. This group is composed of uncharacterized proteins with similarity to LIMK and Testicular or testis-specific protein kinase (TESK). LIMKs are characterized as serine/threonine kinases (STKs) while TESKs are dual-specificity protein kinases. Both LIMK and TESK phosphorylate and inactivate cofilin, an actin depolymerizing factor, to induce the reorganization of the actin cytoskeleton. They are implicated in many cellular functions including cell spreading, motility, morphogenesis, meiosis, mitosis, and spermatogenesis. The LIMK-like subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271058 [Multi-domain]  Cd Length: 256  Bit Score: 46.36  E-value: 4.01e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 729 ISDMRKLSdHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLS----GLSWERRRKIMKGIVEALRFLH----------- 793
Cdd:cd14156    39 ISLLQKLS-HPNIVRYLGICVKDEKLHPILEYVSGGCLEELLAreelPLSWREKVELACDISRGMVYLHskniyhrdlns 117
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 794 --C--RCSPAVVAGNLSPENIVIDVTDEPRLCLGLPGLLCMDAAYMAPETREHKEMTSKSDIYGFGILLLHLLtGKCSSS 869
Cdd:cd14156   118 knCliRVTPRGREAVVTDFGLAREVGEMPANDPERKLSLVGSAFWMAPEMLRGEPYDRKVDVFSFGIVLCEIL-ARIPAD 196
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1780598599 870 NEDIESGVngslvkwarysysnchidtwiDSSIDTSVHqREIV-----HVMNLALKCTAIDPQERPCTNNVLQALE 940
Cdd:cd14156   197 PEVLPRTG---------------------DFGLDVQAF-KEMVpgcpePFLDLAASCCRMDAFKRPSFAELLDELE 250
LRR_8 pfam13855
Leucine rich repeat;
337-397 5.64e-05

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 41.74  E-value: 5.64e-05
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1780598599 337 PRLKVLQLWSNRFSGGIPANLGKHNNLTVLDLSTNNLTGKLPDTLCDSGHLTKLILFSNSL 397
Cdd:pfam13855   1 PNLRSLDLSNNRLTSLDDGAFKGLSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
STKc_LIMK cd14154
Catalytic domain of the Serine/Threonine Kinase, LIM domain kinase; STKs catalyze the transfer ...
715-858 5.67e-05

Catalytic domain of the Serine/Threonine Kinase, LIM domain kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. LIMKs phosphorylate and inactivate cofilin, an actin depolymerizing factor, to induce the reorganization of the actin cytoskeleton. They act downstream of Rho GTPases and are expressed ubiquitously. As regulators of actin dynamics, they contribute to diverse cellular functions such as cell motility, morphogenesis, differentiation, apoptosis, meiosis, mitosis, and neurite extension. LIMKs contain the LIM (two repeats), PDZ, and catalytic kinase domains. Vertebrate have two members, LIMK1 and LIMK2. The LIMK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271056 [Multi-domain]  Cd Length: 272  Bit Score: 45.96  E-value: 5.67e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 715 VVKEVKKYDS------LPEmISDMRKLsDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVL----SGLSWERRRKIMKG 784
Cdd:cd14154    22 VMKELIRFDEeaqrnfLKE-VKVMRSL-DHPNVLKFIGVLYKDKKLNLITEYIPGGTLKDVLkdmaRPLPWAQRVRFAKD 99
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 785 IVEALRFLHCRCspaVVAGNLSPEN---------IVID------VTDEPRLCLGLPGLLCMDAA---------------- 833
Cdd:cd14154   100 IASGMAYLHSMN---IIHRDLNSHNclvredktvVVADfglarlIVEERLPSGNMSPSETLRHLkspdrkkrytvvgnpy 176
                         170       180
                  ....*....|....*....|....*
gi 1780598599 834 YMAPETREHKEMTSKSDIYGFGILL 858
Cdd:cd14154   177 WMAPEMLNGRSYDEKVDIFSFGIVL 201
STKc_Unc-89_rpt2 cd14112
Catalytic kinase domain, second repeat, of the Giant Serine/Threonine Kinase Uncoordinated ...
711-864 6.61e-05

Catalytic kinase domain, second repeat, of the Giant Serine/Threonine Kinase Uncoordinated protein 89; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nematode Unc-89 gene, through alternative promoter use and splicing, encodes at least six major isoforms (Unc-89A to Unc-89F) of giant muscle proteins that are homologs for the vetebrate obscurin. In flies, five isoforms of Unc-89 have been detected: four in the muscles of adult flies (two in the indirect flight muscle and two in other muscles) and another isoform in the larva. Unc-89 in nematodes is required for normal muscle cell architecture. In flies, it is necessary for the development of a symmetrical sarcomere in the flight muscles. Unc-89 proteins contain several adhesion and signaling domains including multiple copies of the immunoglobulin (Ig) domain, as well as fibronectin type III (FN3), SH3, RhoGEF, and PH domains. The nematode Unc-89 isoforms D, C, D, and F contain two kinase domain with B and F having two complete kinase domains while the first repeat of C and D are partial domains. Homology modeling suggests that the first kinase repeat of Unc-89 may be catalytically inactive, a pseudokinase, while the second kinase repeat may be active. The Unc-89 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271014 [Multi-domain]  Cd Length: 259  Bit Score: 45.60  E-value: 6.61e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 711 GVHFVVKEVKKYDSLPEMIS--DMRKLSDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG--LSWERRRKIMKGIV 786
Cdd:cd14112    30 DAHCAVKIFEVSDEASEAVRefESLRTLQHENVQRLIAAFKPSNFAYLVMEKLQEDVFTRFSSNdyYSEEQVATTVRQIL 109
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 787 EALRFLHCRcspAVVAGNLSPENIV-----------IDVTDEPRLCLGLPGLLCMDAAYMAPET-REHKEMTSKSDIYGF 854
Cdd:cd14112   110 DALHYLHFK---GIAHLDVQPDNIMfqsvrswqvklVDFGRAQKVSKLGKVPVDGDTDWASPEFhNPETPITVQSDIWGL 186
                         170
                  ....*....|
gi 1780598599 855 GILLLHLLTG 864
Cdd:cd14112   187 GVLTFCLLSG 196
PKc_TESK cd14155
Catalytic domain of the Dual-specificity protein kinase, Testicular protein kinase; ...
732-862 7.55e-05

Catalytic domain of the Dual-specificity protein kinase, Testicular protein kinase; Dual-specificity PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine as well as tyrosine residues on protein substrates. TESK proteins phosphorylate cofilin and induce actin cytoskeletal reorganization. In the Drosphila eye, TESK is required for epithelial cell organization. Mammals contain two TESK proteins, TESK1 and TESK2, which are highly expressed in testis and play roles in spermatogenesis. TESK1 is found in testicular germ cells while TESK2 is expressed mainly in nongerminal Sertoli cells. TESK1 is stimulated by integrin-mediated signaling pathways. It regulates cell spreading and focal adhesion formation. The TESK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine PKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271057 [Multi-domain]  Cd Length: 253  Bit Score: 45.54  E-value: 7.55e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 732 MRKLSdHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG---LSWERRRKIMKGIVEALRFLHcrcSPAVVAGNLSPE 808
Cdd:cd14155    42 MNRLS-HPNILRFMGVCVHQGQLHALTEYINGGNLEQLLDSnepLSWTVRVKLALDIARGLSYLH---SKGIFHRDLTSK 117
                          90       100       110       120       130       140       150
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 809 NIVIDVTDE---------------PRLCLGLPGLLCMDAAY-MAPETREHKEMTSKSDIYGFGILLLHLL 862
Cdd:cd14155   118 NCLIKRDENgytavvgdfglaekiPDYSDGKEKLAVVGSPYwMAPEVLRGEPYNEKADVFSYGIILCEII 187
PKc_Dusty cd13975
Catalytic domain of the Dual-specificity Protein Kinase, Dusty; Dual-specificity PKs catalyze ...
732-865 7.65e-05

Catalytic domain of the Dual-specificity Protein Kinase, Dusty; Dual-specificity PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine as well as tyrosine residues on protein substrates. Dusty protein kinase is also called Receptor-interacting protein kinase 5 (RIPK5 or RIP5) or RIP-homologous kinase. It is widely distributed in the central nervous system, and may be involved in inducing both caspase-dependent and caspase-independent cell death. The Dusty subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine PKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270877 [Multi-domain]  Cd Length: 262  Bit Score: 45.56  E-value: 7.65e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 732 MRKLSDHKNILKIVATC-------RSETVAYLIHEDVEGKRLSQVLSGLSWERRRKIMKGIVEALRFLHcrcSPAVVAGN 804
Cdd:cd13975    51 TRSLPKHERIVSLHGSVidysyggGSSIAVLLIMERLHRDLYTGIKAGLSLEERLQIALDVVEGIRFLH---SQGLVHRD 127
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1780598599 805 LSPENIVIDVTDEPRLCLGL--PGLLCMDAA------YMAPETREHKEMTSkSDIYGFGILLLHLLTGK 865
Cdd:cd13975   128 IKLKNVLLDKKNRAKITDLGfcKPEAMMSGSivgtpiHMAPELFSGKYDNS-VDVYAFGILFWYLCAGH 195
LRR_8 pfam13855
Leucine rich repeat;
218-277 8.78e-05

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 41.36  E-value: 8.78e-05
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 218 NLKWIYLGYNNLSGEIPYQIGGLSSLNHLDLVYNNLSGPIPPSLGDLKKLEYMFLYQNKL 277
Cdd:pfam13855   2 NLRSLDLSNNRLTSLDDGAFKGLSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
LRR_8 pfam13855
Leucine rich repeat;
193-253 8.78e-05

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 41.36  E-value: 8.78e-05
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1780598599 193 SRLEFLTLASNQLTGGVPVELGKMKNLKWIYLGYNNLSGEIPYQIGGLSSLNHLDLVYNNL 253
Cdd:pfam13855   1 PNLRSLDLSNNRLTSLDDGAFKGLSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
RNA1 COG5238
Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Translation, ...
429-565 8.91e-05

Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Translation, ribosomal structure and biogenesis];


Pssm-ID: 444072 [Multi-domain]  Cd Length: 434  Bit Score: 45.94  E-value: 8.91e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 429 FTKLQLVNFLDLSNNNL--QGNINTWDM----PQLEMLDLSVN-------KFFGELpdFSRSKRLKKLDLSRNKISGvvp 495
Cdd:COG5238   176 ALQNNSVETVYLGCNQIgdEGIEELAEAltqnTTVTTLWLKRNpigdegaEILAEA--LKGNKSLTTLDLSNNQIGD--- 250
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 496 QGLMTFPEIMD-------LDLSENEIT--GVI--PRELSSCKNLVNLDLSHNNFTGE----IPSSFAEFQVLSDLDLSCN 560
Cdd:COG5238   251 EGVIALAEALKnnttvetLYLSGNQIGaeGAIalAKALQGNTTLTSLDLSVNRIGDEgaiaLAEGLQGNKTLHTLNLAYN 330

                  ....*
gi 1780598599 561 QLSGE 565
Cdd:COG5238   331 GIGAQ 335
STKc_HAL4_like cd13994
Catalytic domain of Fungal Halotolerance protein 4-like Serine/Threonine kinases; STKs ...
713-865 1.03e-04

Catalytic domain of Fungal Halotolerance protein 4-like Serine/Threonine kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed of HAL4, Saccharomyces cerevisiae Ptk2/Stk2, and similar fungal proteins. Proteins in this subfamily are involved in regulating ion transporters. In budding and fission yeast, HAL4 promotes potassium ion uptake, which increases cellular resistance to other cations such as sodium, lithium, and calcium ions. HAL4 stabilizes the major high-affinity K+ transporter Trk1 at the plasma membrane under low K+ conditions, which prevents endocytosis and vacuolar degradation. Budding yeast Ptk2 phosphorylates and regulates the plasma membrane H+ ATPase, Pma1. The HAL4-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270896 [Multi-domain]  Cd Length: 265  Bit Score: 44.99  E-value: 1.03e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 713 HFVVKEVKKYDslpemISdmRKLSdHKNILKIVATCRSETVAY-LIHEDVEGKRLSQVLS---GLSWERRRKIMKGIVEA 788
Cdd:cd13994    39 DYVKRLTSEYI-----IS--SKLH-HPNIVKVLDLCQDLHGKWcLVMEYCPGGDLFTLIEkadSLSLEEKDCFFKQILRG 110
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 789 LRFLHcrcSPAVVAGNLSPENIVID------VTD-----------EPRLCLGLPGLLCmdAAYMAPEtrehkEMTSKS-- 849
Cdd:cd13994   111 VAYLH---SHGIAHRDLKPENILLDedgvlkLTDfgtaevfgmpaEKESPMSAGLCGS--EPYMAPE-----VFTSGSyd 180
                         170       180
                  ....*....|....*....|
gi 1780598599 850 ----DIYGFGILLLHLLTGK 865
Cdd:cd13994   181 gravDVWSCGIVLFALFTGR 200
STKc_MLCK-like cd14006
Catalytic kinase domain of Myosin Light Chain Kinase-like Serine/Threonine Kinases; STKs ...
716-937 1.12e-04

Catalytic kinase domain of Myosin Light Chain Kinase-like Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This family is composed of MLCKs and related MLCK-like kinase domains from giant STKs such as titin, obscurin, SPEG, Unc-89, Trio, kalirin, and Twitchin. Also included in this family are Death-Associated Protein Kinases (DAPKs) and Death-associated protein kinase-Related Apoptosis-inducing protein Kinase (DRAKs). MLCK phosphorylates myosin regulatory light chain and controls the contraction of all muscle types. Titin, obscurin, Twitchin, and SPEG are muscle proteins involved in the contractile apparatus. The giant STKs are multidomain proteins containing immunoglobulin (Ig), fibronectin type III (FN3), SH3, RhoGEF, PH and kinase domains. Titin, obscurin, Twitchin, and SPEG contain many Ig domain repeats at the N-terminus, while Trio and Kalirin contain spectrin-like repeats. The MLCK-like family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270908 [Multi-domain]  Cd Length: 247  Bit Score: 44.95  E-value: 1.12e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 716 VKEVKKYDSLPEmISDMRKLsDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG---LSWERRRKIMKGIVEALRFL 792
Cdd:cd14006    28 KRDKKKEAVLRE-ISILNQL-QHPRIIQLHEAYESPTELVLILELCSGGELLDRLAErgsLSEEEVRTYMRQLLEGLQYL 105
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 793 H-CRcspaVVAGNLSPENIVIDVTDEP-----------RLCLGLPGLLCMDAA-YMAPETREHKEMTSKSDIYGFGILLL 859
Cdd:cd14006   106 HnHH----ILHLDLKPENILLADRPSPqikiidfglarKLNPGEELKEIFGTPeFVAPEIVNGEPVSLATDMWSIGVLTY 181
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 860 HLLTGkCS----SSNEDIESGVNGSlvkwaRYSYSNCHIDtwidssiDTSVHQREIvhVMNLALKctaiDPQERPCTNNV 935
Cdd:cd14006   182 VLLSG-LSpflgEDDQETLANISAC-----RVDFSEEYFS-------SVSQEAKDF--IRKLLVK----EPRKRPTAQEA 242

                  ..
gi 1780598599 936 LQ 937
Cdd:cd14006   243 LQ 244
PK_Tyr_Ser-Thr pfam07714
Protein tyrosine and serine/threonine kinase; Protein phosphorylation, which plays a key role ...
708-858 1.43e-04

Protein tyrosine and serine/threonine kinase; Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyze the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyze the reverse process. Protein kinases fall into three broad classes, characterized with respect to substrate specificity; Serine/threonine-protein kinases, tyrosine-protein kinases, and dual specificity protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins). This entry represents the catalytic domain found in a number of serine/threonine- and tyrosine-protein kinases. It does not include the catalytic domain of dual specificity kinases.


Pssm-ID: 462242 [Multi-domain]  Cd Length: 258  Bit Score: 44.79  E-value: 1.43e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 708 DKNGVHFVVKEVKKYDSLPEM------ISDMRKLsDHKNILKIVATCRSETVAYLIHEDVEG----KRLSQVLSGLSWER 777
Cdd:pfam07714  25 ENTKIKVAVKTLKEGADEEERedfleeASIMKKL-DHPNIVKLLGVCTQGEPLYIVTEYMPGgdllDFLRKHKRKLTLKD 103
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 778 RRKIMKGIVEALRFLHCRCspaVVAGNLSPENIVID------VTD--EPRLCLGLPGLLCMDAA-----YMAPETREHKE 844
Cdd:pfam07714 104 LLSMALQIAKGMEYLESKN---FVHRDLAARNCLVSenlvvkISDfgLSRDIYDDDYYRKRGGGklpikWMAPESLKDGK 180
                         170
                  ....*....|....
gi 1780598599 845 MTSKSDIYGFGILL 858
Cdd:pfam07714 181 FTSKSDVWSFGVLL 194
STKc_RSK1_C cd14175
C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 1 (also called ...
712-937 1.55e-04

C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 1 (also called Ribosomal protein S6 kinase alpha-1 or 90kDa ribosomal protein S6 kinase 1); STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. RSK1 is also called S6K-alpha-1, RPS6KA1, p90RSK1 or MAPK-activated protein kinase 1a (MAPKAPK-1a). It is a component of the insulin transduction pathway, regulating the function of IRS1. It also interacts with PKA and promotes its inactivation. RSK1 is one of four RSK isoforms (RSK1-4) from distinct genes present in vertebrates. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. The RSK1 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271077 [Multi-domain]  Cd Length: 291  Bit Score: 44.63  E-value: 1.55e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 712 VHFVVKEVKKYDSLP-EMISDMRKLSDHKNILKIVATCRSETVAYLIHEDVEG-KRLSQVLSGLSWERRRK--IMKGIVE 787
Cdd:cd14175    27 MEYAVKVIDKSKRDPsEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGgELLDKILRQKFFSEREAssVLHTICK 106
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 788 ALRFLHcrcSPAVVAGNLSPENIV-IDVTDEP--------------RLCLGLPGLLCMDAAYMAPETREHKEMTSKSDIY 852
Cdd:cd14175   107 TVEYLH---SQGVVHRDLKPSNILyVDESGNPeslricdfgfakqlRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIW 183
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 853 GFGILLLHLLTGKCSSSN------EDIESGVNGslvkwARYSYSNCHIDTWIDSSIDtsvhqreivhvmnLALKCTAIDP 926
Cdd:cd14175   184 SLGILLYTMLAGYTPFANgpsdtpEEILTRIGS-----GKFTLSGGNWNTVSDAAKD-------------LVSKMLHVDP 245
                         250
                  ....*....|.
gi 1780598599 927 QERPCTNNVLQ 937
Cdd:cd14175   246 HQRLTAKQVLQ 256
PPP1R42 cd21340
protein phosphatase 1 regulatory subunit 42; Protein phosphatase 1 regulatory subunit 42 ...
438-560 1.97e-04

protein phosphatase 1 regulatory subunit 42; Protein phosphatase 1 regulatory subunit 42 (PPP1R42), also known as leucine-rich repeat-containing protein 67 (lrrc67) or testis leucine-rich repeat (TLRR) protein, plays a role in centrosome separation. PPP1R42 has been shown to interact with the well-conserved signaling protein phosphatase-1 (PP1) and thereby increasing PP1's activity, which counters centrosome separation. Inhibition of PPP1R42 expression increases the number of centrosomes per cell while its depletion reduces the activity of PP1 leading to activation of NEK2, the kinase responsible for phosphorylation of centrosomal linker proteins promoting centrosome separation.


Pssm-ID: 411060 [Multi-domain]  Cd Length: 220  Bit Score: 43.62  E-value: 1.97e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 438 LDLSNNNLQ--GNINTwdMPQLEMLDLSVNKFfGELPDFSRSKRLKKLDLSRNKISGV------------------VPQG 497
Cdd:cd21340    29 LYLYDNKITkiENLEF--LTNLTHLYLQNNQI-EKIENLENLVNLKKLYLGGNRISVVeglenltnleelhienqrLPPG 105
                          90       100       110       120       130       140       150
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1780598599 498 L-MTF-PEIMD--------LDLSENEITgvIPRELSSCKNLVNLDLSHNNFT--GEIPSSFAEFQVLSDLDLSCN 560
Cdd:cd21340   106 EkLTFdPRSLAalsnslrvLNISGNNID--SLEPLAPLRNLEQLDASNNQISdlEELLDLLSSWPSLRELDLTGN 178
LRR_8 pfam13855
Leucine rich repeat;
145-205 2.37e-04

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 39.82  E-value: 2.37e-04
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1780598599 145 PNLYTLDLSNNMFTGeIynDIGVF---SNLRVLDLGGNVLTGHVPGYLGNLSRLEFLTLASNQL 205
Cdd:pfam13855   1 PNLRSLDLSNNRLTS-L--DDGAFkglSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
LRR_8 pfam13855
Leucine rich repeat;
169-229 2.75e-04

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 39.82  E-value: 2.75e-04
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1780598599 169 SNLRVLDLGGNVLTGHVPGYLGNLSRLEFLTLASNQLTGGVPVELGKMKNLKWIYLGYNNL 229
Cdd:pfam13855   1 PNLRSLDLSNNRLTSLDDGAFKGLSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
LRR_8 pfam13855
Leucine rich repeat;
527-586 2.80e-04

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 39.82  E-value: 2.80e-04
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 527 NLVNLDLSHNNFTGEIPSSFAEFQVLSDLDLSCNQLSGEIPKNLGNIESLVQVNISHNLL 586
Cdd:pfam13855   2 NLRSLDLSNNRLTSLDDGAFKGLSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
STKc_AGC cd05123
Catalytic domain of AGC family Serine/Threonine Kinases; STKs catalyze the transfer of the ...
734-865 3.83e-04

Catalytic domain of AGC family Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. The AGC family is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase.


Pssm-ID: 270693 [Multi-domain]  Cd Length: 250  Bit Score: 43.27  E-value: 3.83e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 734 KLSDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLS---GLSWERRRKIMKGIVEALRFLHcrcSPAVVAGNLSPENI 810
Cdd:cd05123    48 ERVNHPFIVKLHYAFQTEEKLYLVLDYVPGGELFSHLSkegRFPEERARFYAAEIVLALEYLH---SLGIIYRDLKPENI 124
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1780598599 811 VID------VTDEPRLCLGLPGLLCMDAA-----YMAPETREHKEMTSKSDIYGFGILLLHLLTGK 865
Cdd:cd05123   125 LLDsdghikLTDFGLAKELSSDGDRTYTFcgtpeYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
STKc_Rim15_like cd05611
Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases; STKs catalyze the ...
711-864 4.15e-04

Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. The Rim15-like subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270762 [Multi-domain]  Cd Length: 263  Bit Score: 43.24  E-value: 4.15e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 711 GVHFVVKEVKKYDslpeMISD------------MRKLSDHKNILKIVATCRSETVAYLIHEDVEG---KRLSQVLSGLSW 775
Cdd:cd05611    21 GDYFAIKVLKKSD----MIAKnqvtnvkaeraiMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGgdcASLIKTLGGLPE 96
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 776 ERRRKIMKGIVEALRFLHCRcspAVVAGNLSPENIVIDVTDEPRLCLGLPGLLCMDAA----------YMAPETREHKEM 845
Cdd:cd05611    97 DWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEKRhnkkfvgtpdYLAPETILGVGD 173
                         170
                  ....*....|....*....
gi 1780598599 846 TSKSDIYGFGILLLHLLTG 864
Cdd:cd05611   174 DKMSDWWSLGCVIFEFLFG 192
STKc_CaMKI cd14083
Catalytic domain of the Serine/Threonine kinase, Calcium/calmodulin-dependent protein kinase ...
717-864 6.66e-04

Catalytic domain of the Serine/Threonine kinase, Calcium/calmodulin-dependent protein kinase Type I; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CaMKs are multifunctional calcium and calmodulin (CaM) stimulated STKs involved in cell cycle regulation. There are several types of CaMKs including CaMKI, CaMKII, and CaMKIV. In vertebrates, there are four CaMKI proteins encoded by different genes (alpha, beta, gamma, and delta), each producing at least one variant. CaMKs contain an N-terminal catalytic domain and a C-terminal regulatory domain that harbors a CaM binding site. CaMKI proteins are monomeric and they play pivotal roles in the nervous system, including long-term potentiation, dendritic arborization, neurite outgrowth, and the formation of spines, synapses, and axons. In addition, they may be involved in osteoclast differentiation and bone resorption. The CaMKI subfamily is part of a larger superfamily that includes the catalytic domains of other protein kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270985 [Multi-domain]  Cd Length: 259  Bit Score: 42.74  E-value: 6.66e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 717 KEVK-KYDSLPEMISDMRKLSdHKNILKIVATCRSETVAYLIHEDVEGKRLSQ--VLSGLSWER-RRKIMKGIVEALRFL 792
Cdd:cd14083    39 KALKgKEDSLENEIAVLRKIK-HPNIVQLLDIYESKSHLYLVMELVTGGELFDriVEKGSYTEKdASHLIRQVLEAVDYL 117
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 793 HcrcSPAVVAGNLSPENIVIDVTDEPRL-------CLGLPGLLCMDAA-----YMAPETREHKEMTSKSDIYGFGILLLH 860
Cdd:cd14083   118 H---SLGIVHRDLKPENLLYYSPDEDSKimisdfgLSKMEDSGVMSTAcgtpgYVAPEVLAQKPYGKAVDCWSIGVISYI 194

                  ....
gi 1780598599 861 LLTG 864
Cdd:cd14083   195 LLCG 198
PK_MADML cd14035
Pseudokinase domain of MLF1-ADaptor Molecule-Like; The pseudokinase domain shows similarity to ...
694-936 7.00e-04

Pseudokinase domain of MLF1-ADaptor Molecule-Like; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity and/or ATP binding. MADML has been shown to be expressed throughout development in Xenopus laevis with highest expression found in the developing lens and retina. It may play an important role in embryonic eye development. The MADML subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270937 [Multi-domain]  Cd Length: 263  Bit Score: 42.60  E-value: 7.00e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 694 NTILSSLKDQNVLVDKNGVHFVVKEVKKY--DSLPEMISDMrKLSDHKNILKI------VATCRSETVayLIHEDVEGKR 765
Cdd:cd14035     9 STFLAMDTEEGVEVVWNELFFQDKKAFKAheDKIKTMFENL-TLVDHPNIVKFhkywldVKDNHARVV--FITEYVSSGS 85
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 766 LSQVLSglSWERRRKIMKG---------IVEALRFLHCrCSPAVVAGNLSPENIVID-------------------VTDE 817
Cdd:cd14035    86 LKQFLK--KTKKNHKTMNArawkrwctqILSALSYLHS-CEPPIIHGNLTSDTIFIQhnglikigsvwhrlfvnvlPEGG 162
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 818 PRLCLGLPGLLCMDAAYMAPETREHKEMTSkSDIYGFGILLLHLLTGKCSSSNediESGVNGSLVKWARYSYSNCHIDTW 897
Cdd:cd14035   163 VRGPLRQEREELRNLHFFPPEYGSCEDGTA-VDIFSFGMCALEMAVLEIQANG---DTRVSEEAIARARHSLEDPNMREF 238
                         250       260       270
                  ....*....|....*....|....*....|....*....
gi 1780598599 898 IdssidtsvhqreivhvmnlaLKCTAIDPQERPCTNNVL 936
Cdd:cd14035   239 I--------------------LSCLRHNPCKRPTAHDLL 257
STKc_MSK_C cd14092
C-terminal catalytic domain of the Serine/Threonine Kinase, Mitogen and stress-activated ...
709-811 8.50e-04

C-terminal catalytic domain of the Serine/Threonine Kinase, Mitogen and stress-activated kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270994 [Multi-domain]  Cd Length: 311  Bit Score: 42.67  E-value: 8.50e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 709 KNGVHFVVKEV-KKYDSLPEmISDMRKLSDHKNILKIVATCRSETVAYLIHEDVEGKRLsqvlsglsWERRRK------- 780
Cdd:cd14092    29 KTGQEFAVKIVsRRLDTSRE-VQLLRLCQGHPNIVKLHEVFQDELHTYLVMELLRGGEL--------LERIRKkkrftes 99
                          90       100       110
                  ....*....|....*....|....*....|....*
gi 1780598599 781 ----IMKGIVEALRFLHCRcspAVVAGNLSPENIV 811
Cdd:cd14092   100 easrIMRQLVSAVSFMHSK---GVVHRDLKPENLL 131
STKc_ULK1 cd14202
Catalytic domain of the Serine/Threonine kinase, Unc-51-like kinase 1; STKs catalyze the ...
738-873 8.80e-04

Catalytic domain of the Serine/Threonine kinase, Unc-51-like kinase 1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ATG1/ULK complex is conserved from yeast to humans and it plays a critical role in the initiation of autophagy, the intracellular system that leads to the lysosomal degradation of cellular components and their recycling into basic metabolic units. ULK1 is required for efficient amino acid starvation-induced autophagy and mitochondrial clearance. It associates with three autophagy-related proteins (Atg13, FIP200 amd Atg101) to form the ULK1 complex. All fours proteins are essential for autophagosome formation. ULK1 is regulated by both mammalian target-of rapamycin complex 1 (mTORC1) and AMP-activated protein kinase (AMPK). mTORC1 negatively regulates the ULK1 complex in a nutrient-dependent manner while AMPK stimulates autophagy by inhibiting mTORC1. ULK1 also plays neuron-specific roles and is involved in non-clathrin-coated endocytosis in growth cones, filopodia extension, neurite extension, and axon branching. The ULK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271104 [Multi-domain]  Cd Length: 267  Bit Score: 42.31  E-value: 8.80e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 738 HKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG---LSWERRRKIMKGIVEALRFLHcrcSPAVVAGNLSPENIVIDV 814
Cdd:cd14202    60 HENIVALYDFQEIANSVYLVMEYCNGGDLADYLHTmrtLSEDTIRLFLQQIAGAMKMLH---SKGIIHRDLKPQNILLSY 136
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 815 TDEPRLCLGLPGLLCMD------------AA-------YMAPETREHKEMTSKSDIYGFGILLLHLLTGKC---SSSNED 872
Cdd:cd14202   137 SGGRKSNPNNIRIKIADfgfarylqnnmmAAtlcgspmYMAPEVIMSQHYDAKADLWSIGTIIYQCLTGKApfqASSPQD 216

                  .
gi 1780598599 873 I 873
Cdd:cd14202   217 L 217
STKc_MAP3K8 cd13995
Catalytic domain of the Serine/Threonine kinase, Mitogen-Activated Protein Kinase (MAPK) ...
738-864 8.92e-04

Catalytic domain of the Serine/Threonine kinase, Mitogen-Activated Protein Kinase (MAPK) Kinase Kinase 8; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MAP3K8 is also called Tumor progression locus 2 (Tpl2) or Cancer Osaka thyroid (Cot), and was first identified as a proto-oncogene in T-cell lymphoma induced by MoMuL virus and in breast carcinoma induced by MMTV. Activated MAP3K8 induces various MAPK pathways including Extracellular Regulated Kinase (ERK) 1/2, c-Jun N-terminal kinase (JNK), and p38. It plays a pivotal role in innate immunity, linking Toll-like receptors to the production of TNF and the activation of ERK in macrophages. It is also required in interleukin-1beta production and is critical in host defense against Gram-positive bacteria. MAP3Ks (MKKKs or MAPKKKs) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. The MAP3K8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270897 [Multi-domain]  Cd Length: 256  Bit Score: 42.30  E-value: 8.92e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 738 HKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSGLSWERRRKIM---KGIVEALRFLHcrcSPAVVAGNLSPENIVIDV 814
Cdd:cd13995    55 HENIAELYGALLWEETVHLFMEAGEGGSVLEKLESCGPMREFEIIwvtKHVLKGLDFLH---SKNIIHHDIKPSNIVFMS 131
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 815 TDEPRLCLGLPGLLCMDA----------AYMAPETREHKEMTSKSDIYGFGILLLHLLTG 864
Cdd:cd13995   132 TKAVLVDFGLSVQMTEDVyvpkdlrgteIYMSPEVILCRGHNTKADIYSLGATIIHMQTG 191
STKc_GAK_like cd13985
Catalytic domain of cyclin G-Associated Kinase-like proteins; STKs catalyze the transfer of ...
713-863 9.24e-04

Catalytic domain of cyclin G-Associated Kinase-like proteins; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily includes cyclin G-Associated Kinase (GAK), Drosophila melanogaster Numb-Associated Kinase (NAK)-like proteins, and similar protein kinases. GAK plays regulatory roles in clathrin-mediated membrane trafficking, the maintenance of centrosome integrity and chromosome congression, neural patterning, survival of neurons, and immune responses. NAK plays a role in asymmetric cell division through its association with Numb. It also regulates the localization of Dlg, a protein essential for septate junction formation. The GAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270887 [Multi-domain]  Cd Length: 272  Bit Score: 42.32  E-value: 9.24e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 713 HFVVKEVKKYDSLPEMISDMRKLSDHKNIlkivatcrsetVAYLIHEDVEGKRLSQVL-------------------SGL 773
Cdd:cd13985    32 RMYFNDEEQLRVAIKEIEIMKRLCGHPNI-----------VQYYDSAILSSEGRKEVLllmeycpgslvdileksppSPL 100
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 774 SWERRRKIMKGIVEALRFLHCrCSPAVVAGNLSPENI--------------------VIDVTDEPRLCLGLPGLLCMDAA 833
Cdd:cd13985   101 SEEEVLRIFYQICQAVGHLHS-QSPPIIHRDIKIENIlfsntgrfklcdfgsattehYPLERAEEVNIIEEEIQKNTTPM 179
                         170       180       190
                  ....*....|....*....|....*....|...
gi 1780598599 834 YMAPET---REHKEMTSKSDIYGFGILLLHLLT 863
Cdd:cd13985   180 YRAPEMidlYSKKPIGEKADIWALGCLLYKLCF 212
STKc_cGK cd05572
Catalytic domain of the Serine/Threonine Kinase, cGMP-dependent protein kinase (cGK or PKG); ...
705-872 1.20e-03

Catalytic domain of the Serine/Threonine Kinase, cGMP-dependent protein kinase (cGK or PKG); STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270724 [Multi-domain]  Cd Length: 262  Bit Score: 41.83  E-value: 1.20e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 705 VLVDKNGVHFVVKEVKKY----DSLPEMISDMRKL---SDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG---LS 774
Cdd:cd05572    12 VQLKSKGRTFALKCVKKRhivqTRQQEHIFSEKEIleeCNSPFIVKLYRTFKDKKYLYMLMEYCLGGELWTILRDrglFD 91
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 775 WERRRKIMKGIVEALRFLHCRcspAVVAGNLSPENIVID------VTDeprlclglpgllcMDAA--------------- 833
Cdd:cd05572    92 EYTARFYTACVVLAFEYLHSR---GIIYRDLKPENLLLDsngyvkLVD-------------FGFAkklgsgrktwtfcgt 155
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|...
gi 1780598599 834 --YMAPETREHKEMTSKSDIYGFGILLLHLLTGKC--SSSNED 872
Cdd:cd05572   156 peYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPpfGGDDED 198
STKc_YSK4 cd06631
Catalytic domain of the Serine/Threonine Kinase, Yeast Sps1/Ste20-related Kinase 4; STKs ...
720-865 1.21e-03

Catalytic domain of the Serine/Threonine Kinase, Yeast Sps1/Ste20-related Kinase 4; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs phosphorylate and activate MAPK kinases, which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270801 [Multi-domain]  Cd Length: 266  Bit Score: 41.65  E-value: 1.21e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 720 KKYDSLPEMIsDMRKLSDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLS---GLSWERRRKIMKGIVEALRFLHCRC 796
Cdd:cd06631    45 KEYEKLQEEV-DLLKTLKHVNIVGYLGTCLEDNVVSIFMEFVPGGSIASILArfgALEEPVFCRYTKQILEGVAYLHNNN 123
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 797 spaVV-----AGN--LSPENIV--IDVTDEPRLCLGLPGLLCMDAA--------YMAPETREHKEMTSKSDIYGFGILLL 859
Cdd:cd06631   124 ---VIhrdikGNNimLMPNGVIklIDFGCAKRLCINLSSGSQSQLLksmrgtpyWMAPEVINETGHGRKSDIWSIGCTVF 200

                  ....*.
gi 1780598599 860 HLLTGK 865
Cdd:cd06631   201 EMATGK 206
STKc_RSK3_C cd14178
C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 3 (also called ...
712-937 1.27e-03

C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 3 (also called Ribosomal protein S6 kinase alpha-2 or 90kDa ribosomal protein S6 kinase 2); STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. RSK3 is also called S6K-alpha-2, RPS6KA2, p90RSK2 or MAPK-activated protein kinase 1c (MAPKAPK-1c). RSK3 binds muscle A-kinase anchoring protein (mAKAP)-b directly and regulates concentric cardiac myocyte growth. The RSK3 gene, RPS6KA2, is a putative tumor suppressor gene in sporadic epithelial ovarian cancer and variations to the gene may be associated with rectal cancer risk. RSK3 is one of four RSK isoforms (RSK1-4) from distinct genes present in vertebrates. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. The RSK3 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271080 [Multi-domain]  Cd Length: 293  Bit Score: 41.92  E-value: 1.27e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 712 VHFVVKEVKKYDSLP-EMISDMRKLSDHKNILKIVATCRSETVAYLIHEDVEG-KRLSQVLSGLSWERRR--KIMKGIVE 787
Cdd:cd14178    29 TEYAVKIIDKSKRDPsEEIEILLRYGQHPNIITLKDVYDDGKFVYLVMELMRGgELLDRILRQKCFSEREasAVLCTITK 108
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 788 ALRFLHcrcSPAVVAGNLSPENIV-IDVTDEP--------------RLCLGLPGLLCMDAAYMAPETREHKEMTSKSDIY 852
Cdd:cd14178   109 TVEYLH---SQGVVHRDLKPSNILyMDESGNPesiricdfgfakqlRAENGLLMTPCYTANFVAPEVLKRQGYDAACDIW 185
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 853 GFGILLLHLLTGKCSSSN------EDIESGVnGSlvkwARYSYSNCHIDTWIDSSIDtsvhqreivhvmnLALKCTAIDP 926
Cdd:cd14178   186 SLGILLYTMLAGFTPFANgpddtpEEILARI-GS----GKYALSGGNWDSISDAAKD-------------IVSKMLHVDP 247
                         250
                  ....*....|.
gi 1780598599 927 QERPCTNNVLQ 937
Cdd:cd14178   248 HQRLTAPQVLR 258
STKc_Chk1 cd14069
Catalytic domain of the Serine/Threonine kinase, Checkpoint kinase 1; STKs catalyze the ...
716-864 1.27e-03

Catalytic domain of the Serine/Threonine kinase, Checkpoint kinase 1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Chk1 is implicated in many major checkpoints of the cell cycle, providing a link between upstream sensors and the cell cycle engine. It plays an important role in DNA damage response and maintaining genomic stability. Chk1 acts as an effector of the sensor kinase, ATR (ATM and Rad3-related), a member of the PI3K family, which is activated upon DNA replication stress. Chk1 delays mitotic entry in response to replication blocks by inhibiting cyclin dependent kinase (Cdk) activity. In addition, Chk1 contributes to the function of centrosome and spindle-based checkpoints, inhibits firing of origins of DNA replication (Ori), and represses transcription of cell cycle proteins including cyclin B and Cdk1. The Chk1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270971 [Multi-domain]  Cd Length: 261  Bit Score: 41.55  E-value: 1.27e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 716 VKEVKKYDSLPEMISDMRK------LSDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLS---GLSWERRRKIMKGIV 786
Cdd:cd14069    31 VKFVDMKRAPGDCPENIKKevciqkMLSHKNVVRFYGHRREGEFQYLFLEYASGGELFDKIEpdvGMPEDVAQFYFQQLM 110
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 787 EALRFLHcrcSPAVVAGNLSPENIVIDVTDE---------PRLCLGLPGLLCMDAA----YMAPE-TREHKEMTSKSDIY 852
Cdd:cd14069   111 AGLKYLH---SCGITHRDIKPENLLLDENDNlkisdfglaTVFRYKGKERLLNKMCgtlpYVAPElLAKKKYRAEPVDVW 187
                         170
                  ....*....|..
gi 1780598599 853 GFGILLLHLLTG 864
Cdd:cd14069   188 SCGIVLFAMLAG 199
STKc_Titin cd14104
Catalytic domain of the Giant Serine/Threonine Kinase Titin; STKs catalyze the transfer of the ...
738-889 1.49e-03

Catalytic domain of the Giant Serine/Threonine Kinase Titin; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Titin, also called connectin, is a muscle-specific elastic protein and is the largest known protein to date. It contains multiple immunoglobulin (Ig)-like and fibronectin type III (FN3) domains, and a single kinase domain near the C-terminus. It spans half of the sarcomere, the repeating contractile unit of striated muscle, and performs mechanical and catalytic functions. Titin contributes to the passive force generated when muscle is stretched during relaxation. Its kinase domain phosphorylates and regulates the muscle protein telethonin, which is required for sarcomere formation in differentiating myocytes. In addition, titin binds many sarcomere proteins and acts as a molecular scaffold for filament formation during myofibrillogenesis. The Titin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271006 [Multi-domain]  Cd Length: 277  Bit Score: 41.77  E-value: 1.49e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 738 HKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSGLSWE-RRRKIM---KGIVEALRFLHcrcSPAVVAGNLSPENIV-- 811
Cdd:cd14104    55 HRNILRLHESFESHEELVMIFEFISGVDIFERITTARFElNEREIVsyvRQVCEALEFLH---SKNIGHFDIRPENIIyc 131
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 812 ------IDVTDEPRLCLG----LPGLLCMDAAYMAPETREHKEMTSKSDIYGFGILLLHLLTGK---CSSSNEDIESGVN 878
Cdd:cd14104   132 trrgsyIKIIEFGQSRQLkpgdKFRLQYTSAEFYAPEVHQHESVSTATDMWSLGCLVYVLLSGInpfEAETNQQTIENIR 211
                         170
                  ....*....|.
gi 1780598599 879 GslvkwARYSY 889
Cdd:cd14104   212 N-----AEYAF 217
STKc_LIMK1 cd14221
Catalytic domain of the Serine/Threonine Kinase, LIM domain kinase 1; STKs catalyze the ...
715-862 1.52e-03

Catalytic domain of the Serine/Threonine Kinase, LIM domain kinase 1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. LIMK1 activation is induced by bone morphogenic protein, vascular endothelial growth factor, and thrombin. It plays roles in microtubule disassembly and cell cycle progression, and is critical in the regulation of neurite outgrowth. LIMK1 knockout mice show abnormalities in dendritic spine morphology and synaptic function. LIMK1 is one of the genes deleted in patients with Williams Syndrome, which is characterized by distinct craniofacial features, cardiovascular problems, as well as behavioral and neurological abnormalities. LIMKs phosphorylate and inactivate cofilin, an actin depolymerizing factor, to induce the reorganization of the actin cytoskeleton. They act downstream of Rho GTPases and are expressed ubiquitously. As regulators of actin dynamics, they contribute to diverse cellular functions such as cell motility, morphogenesis, differentiation, apoptosis, meiosis, mitosis, and neurite extension. LIMKs contain the LIM (two repeats), PDZ, and catalytic kinase domains. The LIMK1 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271123 [Multi-domain]  Cd Length: 267  Bit Score: 41.48  E-value: 1.52e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 715 VVKEVKKYD-----SLPEMISDMRKLsDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSGLS----WERRRKIMKGI 785
Cdd:cd14221    22 VMKELIRFDeetqrTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDshypWSQRVSFAKDI 100
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 786 VEALRFLH---------------CRCSPAVVAGNLSPENIVIDVTDEPRLCLGLPGLLCM-------DAAYMAPETREHK 843
Cdd:cd14221   101 ASGMAYLHsmniihrdlnshnclVRENKSVVVADFGLARLMVDEKTQPEGLRSLKKPDRKkrytvvgNPYWMAPEMINGR 180
                         170
                  ....*....|....*....
gi 1780598599 844 EMTSKSDIYGFGILLLHLL 862
Cdd:cd14221   181 SYDEKVDVFSFGIVLCEII 199
STKc_RSK4_C cd14177
C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 4 (also called ...
712-937 1.53e-03

C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 4 (also called Ribosomal protein S6 kinase alpha-6 or 90kDa ribosomal protein S6 kinase 6); STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. RSK4 is also called S6K-alpha-6, RPS6KA6, p90RSK6 or pp90RSK4. RSK4 is a substrate of ERK and is a modulator of p53-dependent proliferation arrest in human cells. Deletion of the RSK4 gene, RPS6KA6, frequently occurs in patients of X-linked deafness type 3, mental retardation and choroideremia. Studies of RSK4 in cancer cells and tissues suggest that it may be oncogenic or tumor suppressive depending on many factors. RSK4 is one of four RSK isoforms (RSK1-4) from distinct genes present in vertebrates. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. The RSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271079 [Multi-domain]  Cd Length: 295  Bit Score: 41.54  E-value: 1.53e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 712 VHFVVKEVKKYDSLP-EMISDMRKLSDHKNILKIVATCRSETVAYLIHEDVEG-KRLSQVLSGLSWERRRK--IMKGIVE 787
Cdd:cd14177    30 MEFAVKIIDKSKRDPsEEIEILMRYGQHPNIITLKDVYDDGRYVYLVTELMKGgELLDRILRQKFFSEREAsaVLYTITK 109
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 788 ALRFLHCRcspAVVAGNLSPENIV----------IDVTD-----EPRLCLGLPGLLCMDAAYMAPETREHKEMTSKSDIY 852
Cdd:cd14177   110 TVDYLHCQ---GVVHRDLKPSNILymddsanadsIRICDfgfakQLRGENGLLLTPCYTANFVAPEVLMRQGYDAACDIW 186
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 853 GFGILLLHLLTGKCSSSN------EDIESGVnGSlvkwARYSYSNCHIDTWIDSSIDTSVHqreIVHVmnlalkctaiDP 926
Cdd:cd14177   187 SLGVLLYTMLAGYTPFANgpndtpEEILLRI-GS----GKFSLSGGNWDTVSDAAKDLLSH---MLHV----------DP 248
                         250
                  ....*....|.
gi 1780598599 927 QERPCTNNVLQ 937
Cdd:cd14177   249 HQRYTAEQVLK 259
PKc_MKK3_6 cd06617
Catalytic domain of the dual-specificity Protein Kinases, Mitogen-activated protein Kinase ...
780-865 1.67e-03

Catalytic domain of the dual-specificity Protein Kinases, Mitogen-activated protein Kinase Kinases 3 and 6; PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine (ST) or tyrosine residues on protein substrates. MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 play roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. The MKK3/6 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 173729 [Multi-domain]  Cd Length: 283  Bit Score: 41.64  E-value: 1.67e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 780 KIMKGIVEALRFLHCRCSpaVVAGNLSPENIVIDVTDEPRL-------CLGLPGLLCMDAA---YMAPE----TREHKEM 845
Cdd:cd06617   107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLcdfgisgYLVDSVAKTIDAGckpYMAPErinpELNQKGY 184
                          90       100
                  ....*....|....*....|
gi 1780598599 846 TSKSDIYGFGILLLHLLTGK 865
Cdd:cd06617   185 DVKSDVWSLGITMIELATGR 204
STKc_CASK cd14094
Catalytic domain of the Serine/Threonine Kinase, Calcium/calmodulin-dependent serine protein ...
738-929 1.86e-03

Catalytic domain of the Serine/Threonine Kinase, Calcium/calmodulin-dependent serine protein kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CASK belongs to the MAGUK (membrane-associated guanylate kinase) protein family, which functions as multiple domain adaptor proteins and is characterized by the presence of a core of three domains: PDZ, SH3, and guanylate kinase (GuK). The enzymatically inactive GuK domain in MAGUK proteins mediates protein-protein interactions and associates intramolecularly with the SH3 domain. In addition, CASK contains a catalytic kinase and two L27 domains. It is highly expressed in the nervous system and plays roles in synaptic protein targeting, neural development, and regulation of gene expression. Binding partners include parkin (a Parkinson's disease molecule), neurexin (adhesion molecule), syndecans, calcium channel proteins, CINAP (nucleosome assembly protein), transcription factor Tbr-1, and the cytoplasmic adaptor proteins Mint1, Veli/mLIN-7/MALS, SAP97, caskin, and CIP98. Deletion or mutations in the CASK gene have been implicated in X-linked mental retardation. The CASK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270996 [Multi-domain]  Cd Length: 300  Bit Score: 41.37  E-value: 1.86e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 738 HKNILKIVATCRSETVAYLIHEDVEGKRL-----SQVLSGLSWERR--RKIMKGIVEALRFLHCRcspAVVAGNLSPENI 810
Cdd:cd14094    64 HPHIVELLETYSSDGMLYMVFEFMDGADLcfeivKRADAGFVYSEAvaSHYMRQILEALRYCHDN---NIIHRDVKPHCV 140
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 811 VIDVTDEPRLCLGLPGLLCMDAA--------------YMAPETREHKEMTSKSDIYGFGILLLHLLTGKC--SSSNEDIE 874
Cdd:cd14094   141 LLASKENSAPVKLGGFGVAIQLGesglvaggrvgtphFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLpfYGTKERLF 220
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*
gi 1780598599 875 SGVngslvkwARYSYSnchIDTWIDSSIDTSVHqreivhvmNLALKCTAIDPQER 929
Cdd:cd14094   221 EGI-------IKGKYK---MNPRQWSHISESAK--------DLVRRMLMLDPAER 257
PTZ00283 PTZ00283
serine/threonine protein kinase; Provisional
834-936 2.04e-03

serine/threonine protein kinase; Provisional


Pssm-ID: 240344 [Multi-domain]  Cd Length: 496  Bit Score: 41.78  E-value: 2.04e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 834 YMAPETREHKEMTSKSDIYGFGILLLHLLTGKCSSSNEDIESGVNGSLVkwARYsysnchiDTWIDSsidTSVHQREIVH 913
Cdd:PTZ00283  211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA--GRY-------DPLPPS---ISPEMQEIVT 278
                          90       100
                  ....*....|....*....|...
gi 1780598599 914 vmnlALKCTaiDPQERPCTNNVL 936
Cdd:PTZ00283  279 ----ALLSS--DPKRRPSSSKLL 295
RNA1 COG5238
Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Translation, ...
194-439 2.14e-03

Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Translation, ribosomal structure and biogenesis];


Pssm-ID: 444072 [Multi-domain]  Cd Length: 434  Bit Score: 41.70  E-value: 2.14e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 194 RLEFLTLASNQLTGGVPVELGKM----KNLKWIYLGYNNLSGEIPYQIG----GLSSLNHLDLVYNNLSGPIPPSLGDL- 264
Cdd:COG5238   181 SVETVYLGCNQIGDEGIEELAEAltqnTTVTTLWLKRNPIGDEGAEILAealkGNKSLTTLDLSNNQIGDEGVIALAEAl 260
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 265 ---KKLEYMFLYQNKLSGQIPPSIFSL----QNLISLDFSDNSLSGE----IPELVAQMQSLEILHLFSNNLTgkiPEGV 333
Cdd:COG5238   261 knnTTVETLYLSGNQIGAEGAIALAKAlqgnTTLTSLDLSVNRIGDEgaiaLAEGLQGNKTLHTLNLAYNGIG---AQGA 337
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 334 TSLPrlkvlqlwsnrfsggipANLGKHNNLTVLDLSTNNLTGKLPDTLCDS----GHLTKLILFSNSLDSQIPPSLGmcQ 409
Cdd:COG5238   338 IALA-----------------KALQENTTLHSLDLSDNQIGDEGAIALAKYlegnTTLRELNLGKNNIGKQGAEALI--D 398
                         250       260       270
                  ....*....|....*....|....*....|
gi 1780598599 410 SLERVRLQNNGFSGKLPRGFTKLQLVNFLD 439
Cdd:COG5238   399 ALQTNRLHTLILDGNLIGAEAQQRLEQLLE 428
STKc_RSK2_C cd14176
C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 2 (also called ...
711-870 2.76e-03

C-terminal catalytic domain of the Serine/Threonine Kinase, Ribosomal S6 kinase 2 (also called 90kDa ribosomal protein S6 kinase 3 or Ribosomal protein S6 kinase alpha-3); STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. RSK2 is also called p90RSK3, RPS6KA3, S6K-alpha-3, or MAPK-activated protein kinase 1b (MAPKAPK-1b). RSK2 is expressed highly in the regions of the brain with high synaptic activity. It plays a role in the maintenance and consolidation of excitatory synapses. It is a specific modulator of phospholipase D in calcium-regulated exocytosis. Mutations in the RSK2 gene, RPS6KA3, cause Coffin-Lowry syndrome (CLS), a rare syndromic form of X-linked mental retardation characterized by growth and psychomotor retardation and skeletal abnormalities. RSK2 is one of four RSK isoforms (RSK1-4) from distinct genes present in vertebrates. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. The RSK2 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271078 [Multi-domain]  Cd Length: 339  Bit Score: 41.16  E-value: 2.76e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 711 GVHFVVKEVKKYDSLP-EMISDMRKLSDHKNILKIVATCRSETVAYLIHEDVEG-KRLSQVLSGLSWERRRK--IMKGIV 786
Cdd:cd14176    44 NMEFAVKIIDKSKRDPtEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGgELLDKILRQKFFSEREAsaVLFTIT 123
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 787 EALRFLHcrcSPAVVAGNLSPENIV-IDVTDEP--------------RLCLGLPGLLCMDAAYMAPETREHKEMTSKSDI 851
Cdd:cd14176   124 KTVEYLH---AQGVVHRDLKPSNILyVDESGNPesiricdfgfakqlRAENGLLMTPCYTANFVAPEVLERQGYDAACDI 200
                         170
                  ....*....|....*....
gi 1780598599 852 YGFGILLLHLLTGKCSSSN 870
Cdd:cd14176   201 WSLGVLLYTMLTGYTPFAN 219
LRR_4 pfam12799
Leucine Rich repeats (2 copies); Leucine rich repeats are short sequence motifs present in a ...
123-161 3.50e-03

Leucine Rich repeats (2 copies); Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains.


Pssm-ID: 463713 [Multi-domain]  Cd Length: 44  Bit Score: 36.07  E-value: 3.50e-03
                          10        20        30
                  ....*....|....*....|....*....|....*....
gi 1780598599 123 PSLRYLNLSNNNFSGSIPRGFLPNLYTLDLSNNMFTGEI 161
Cdd:pfam12799   1 PNLEVLDLSNNQITDIPPLAKLPNLETLDLSGNNKITDL 39
STKc_HUNK cd14070
Catalytic domain of the Serine/Threonine Kinase, Hormonally up-regulated Neu-associated kinase ...
714-864 3.64e-03

Catalytic domain of the Serine/Threonine Kinase, Hormonally up-regulated Neu-associated kinase (also called MAK-V); STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. HUNK/MAK-V was identified from a mammary tumor in an MMTV-neu transgenic mouse. It is required for the metastasis of c-myc-induced mammary tumors, but is not necessary for c-myc-induced primary tumor formation or normal development. It is required for HER2/neu-induced tumor formation and maintenance of the cells' tumorigenic phenotype. It is over-expressed in aggressive subsets of ovary, colon, and breast carcinomas. HUNK interacts with synaptopodin, and may also play a role in synaptic plasticity. The HUNK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270972 [Multi-domain]  Cd Length: 262  Bit Score: 40.19  E-value: 3.64e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 714 FVVKEVKKYDSLPEMISdmrklsdHKNILKIVATCRSETVAYLIHEDVEGKRLSQVL---SGLSWERRRKIMKGIVEALR 790
Cdd:cd14070    45 YVTKNLRREGRIQQMIR-------HPNITQLLDILETENSYYLVMELCPGGNLMHRIydkKRLEEREARRYIRQLVSAVE 117
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 791 FLHCRcspAVVAGNLSPENIVIDVTDEPRL-------------CLGLPGLLCMDAAYMAPETREHKEMTSKSDIYGFGIL 857
Cdd:cd14070   118 HLHRA---GVVHRDLKIENLLLDENDNIKLidfglsncagilgYSDPFSTQCGSPAYAAPELLARKKYGPKVDVWSIGVN 194

                  ....*..
gi 1780598599 858 LLHLLTG 864
Cdd:cd14070   195 MYAMLTG 201
STKc_DRAK cd14106
Catalytic domain of the Serine/Threonine Kinase, Death-associated protein kinase-Related ...
711-864 4.03e-03

Catalytic domain of the Serine/Threonine Kinase, Death-associated protein kinase-Related Apoptosis-inducing protein Kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. DRAKs, also called STK17, were named based on their similarity (around 50% identity) to the kinase domain of DAPKs. They contain an N-terminal kinase domain and a C-terminal regulatory domain. Vertebrates contain two subfamily members, DRAK1 and DRAK2. Both DRAKs are localized to the nucleus, autophosphorylate themselves, and phosphorylate myosin light chain as a substrate. They may play a role in apoptotic signaling. The DRAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271008 [Multi-domain]  Cd Length: 268  Bit Score: 40.03  E-value: 4.03e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 711 GVHFVVKEVKK----YDSLPEMISDMRKL---SDHKNI--LKIVATCRSETVayLIHEDVEGKRLSQVLSG---LSWERR 778
Cdd:cd14106    33 GKEYAAKFLRKrrrgQDCRNEILHEIAVLelcKDCPRVvnLHEVYETRSELI--LILELAAGGELQTLLDEeecLTEADV 110
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 779 RKIMKGIVEALRFLHCRcspAVVAGNLSPENIVIDVTDE-----------PRLCLGLPGLLCMDAA--YMAPETREHKEM 845
Cdd:cd14106   111 RRLMRQILEGVQYLHER---NIVHLDLKPQNILLTSEFPlgdiklcdfgiSRVIGEGEEIREILGTpdYVAPEILSYEPI 187
                         170
                  ....*....|....*....
gi 1780598599 846 TSKSDIYGFGILLLHLLTG 864
Cdd:cd14106   188 SLATDMWSIGVLTYVLLTG 206
LRR_8 pfam13855
Leucine rich repeat;
502-562 4.07e-03

Leucine rich repeat;


Pssm-ID: 404697 [Multi-domain]  Cd Length: 61  Bit Score: 36.35  E-value: 4.07e-03
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1780598599 502 PEIMDLDLSENEITGVIPRELSSCKNLVNLDLSHNNFTGEIPSSFAEFQVLSDLDLSCNQL 562
Cdd:pfam13855   1 PNLRSLDLSNNRLTSLDDGAFKGLSNLKVLDLSNNLLTTLSPGAFSGLPSLRYLDLSGNRL 61
LRR_RI cd00116
Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 ...
73-160 5.43e-03

Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).


Pssm-ID: 238064 [Multi-domain]  Cd Length: 319  Bit Score: 40.03  E-value: 5.43e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599  73 RVVSLDLSGKNMSGQILTAATFR-LPFLQTINLSNNNLSGPIP---HDIFTTSSPSLRYLNLSNNNF--SGSIP-RGFLP 145
Cdd:cd00116   196 EVLDLNNNGLTDEGASALAETLAsLKSLEVLNLGDNNLTDAGAaalASALLSPNISLLTLSLSCNDItdDGAKDlAEVLA 275
                          90
                  ....*....|....*...
gi 1780598599 146 N---LYTLDLSNNMFTGE 160
Cdd:cd00116   276 EkesLLELDLRGNKFGEE 293
STKc_MOK cd07831
Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase; STKs ...
700-813 5.43e-03

Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270825 [Multi-domain]  Cd Length: 282  Bit Score: 39.95  E-value: 5.43e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 700 LKDQNVlvdKNGVHFVVKEVKK-YDSLPEM-----ISDMRKLSDHKNILKIVAtcrsetvaylIHEDVEGKRLSQVLS-- 771
Cdd:cd07831    16 LKAQSR---KTGKYYAIKCMKKhFKSLEQVnnlreIQALRRLSPHPNILRLIE----------VLFDRKTGRLALVFElm 82
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*
gi 1780598599 772 -------------GLSWERRRKIMKGIVEALRFLHcRCspAVVAGNLSPENIVID 813
Cdd:cd07831    83 dmnlyelikgrkrPLPEKRVKNYMYQLLKSLDHMH-RN--GIFHRDIKPENILIK 134
STKc_BRSK1_2 cd14081
Catalytic domain of Brain-specific serine/threonine-protein kinases 1 and 2; STKs catalyze the ...
708-875 6.86e-03

Catalytic domain of Brain-specific serine/threonine-protein kinases 1 and 2; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. BRSK1, also called SAD-B or SAD1 (Synapses of Amphids Defective homolog 1), and BRSK2, also called SAD-A, are highly expressed in mammalian forebrain. They play important roles in establishing neuronal polarity. BRSK1/2 double knock-out mice die soon after birth, showing thin cerebral cortices due to disordered subplate layers and neurons that lack distinct axons and dendrites. BRSK1 regulates presynaptic neurotransmitter release. Its activity fluctuates during cell cysle progression and it acts as a regulator of centrosome duplication. BRSK2 is also abundant in pancreatic islets, where it is involved in the regulation of glucose-stimulated insulin secretion. The BRSK1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270983 [Multi-domain]  Cd Length: 255  Bit Score: 39.54  E-value: 6.86e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 708 DKNGVHFVVKEVKKYDSLP---EM-ISDMrKLSDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLS---GLSWERRRK 780
Cdd:cd14081    27 QKVAIKIVNKEKLSKESVLmkvEReIAIM-KLIEHPNVLKLYDVYENKKYLYLVLEYVSGGELFDYLVkkgRLTEKEARK 105
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 781 IMKGIVEALRFLHCRCspaVVAGNLSPENIVIDVTDEPRLCLGLPGLLCMDAA----------YMAPETREHKEMT-SKS 849
Cdd:cd14081   106 FFRQIISALDYCHSHS---ICHRDLKPENLLLDEKNNIKIADFGMASLQPEGSlletscgsphYACPEVIKGEKYDgRKA 182
                         170       180
                  ....*....|....*....|....*.
gi 1780598599 850 DIYGFGILLLHLLTGKCSSSNEDIES 875
Cdd:cd14081   183 DIWSCGVILYALLVGALPFDDDNLRQ 208
STKc_ULK2 cd14201
Catalytic domain of the Serine/Threonine kinase, Unc-51-like kinase 2; STKs catalyze the ...
738-865 7.37e-03

Catalytic domain of the Serine/Threonine kinase, Unc-51-like kinase 2; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ATG1/ULK complex is conserved from yeast to humans and it plays a critical role in the initiation of autophagy, the intracellular system that leads to the lysosomal degradation of cellular components and their recycling into basic metabolic units. ULK2 is ubiquitously expressed and is essential in autophagy induction. It displays partially redundant functions with ULK1 and is able to compensate for the loss of ULK1 in non-selective autophagy. It also displays neuron-specific functions and is important in axon development. The ULK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271103 [Multi-domain]  Cd Length: 271  Bit Score: 39.61  E-value: 7.37e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 738 HKNILKIVATCRSETVAYLIHEDVEGKRLSQVLSG---LSWERRRKIMKGIVEALRFLHcrcSPAVVAGNLSPENIVIDV 814
Cdd:cd14201    64 HENIVALYDVQEMPNSVFLVMEYCNGGDLADYLQAkgtLSEDTIRVFLQQIAAAMRILH---SKGIIHRDLKPQNILLSY 140
                          90       100       110       120       130       140       150
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 815 TDEPRLCLGLPGLLCMD------------AA-------YMAPETREHKEMTSKSDIYGFGILLLHLLTGK 865
Cdd:cd14201   141 ASRKKSSVSGIRIKIADfgfarylqsnmmAAtlcgspmYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGK 210
STKc_CDKL cd07833
Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases; STKs ...
717-813 7.46e-03

Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270827 [Multi-domain]  Cd Length: 288  Bit Score: 39.61  E-value: 7.46e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 717 KEVKKYdSLPEmISDMRKLSdHKNILKIVATCRSETVAYLIHEDVEgKRLSQVL----SGLSWERRRKIMKGIVEALRFL 792
Cdd:cd07833    41 EDVKKT-ALRE-VKVLRQLR-HENIVNLKEAFRRKGRLYLVFEYVE-RTLLELLeaspGGLPPDAVRSYIWQLLQAIAYC 116
                          90       100
                  ....*....|....*....|.
gi 1780598599 793 HcrcSPAVVAGNLSPENIVID 813
Cdd:cd07833   117 H---SHNIIHRDIKPENILVS 134
PK_TRB1 cd14023
Pseudokinase domain of Tribbles Homolog 1; The pseudokinase domain shows similarity to protein ...
718-865 9.69e-03

Pseudokinase domain of Tribbles Homolog 1; The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. TRB1 interacts directly with the mitogen activated protein kinase (MAPK) kinase MKK4, an activator of JNK. It regulates vascular smooth muscle cell proliferation and chemotaxis through the JNK signaling pathway. It is found to be down-regulated in human acute myeloid leukaemia (AML) and may play a role in the pathogenesis of the disease. It has also been identified as a potential biomarker for antibody-mediated allograft failure. TRB1 is one of three Tribbles Homolog (TRB) proteins present in vertebrates that are encoded by three separate genes. TRB proteins interact with many proteins involved in signalling pathways. They play scaffold-like regulatory functions and affect many cellular processes such as mitosis, apoptosis, and gene expression. The TRB1 subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270925 [Multi-domain]  Cd Length: 242  Bit Score: 38.88  E-value: 9.69e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 718 EVKKYDSLPEMISDMRKLSDHKNILKIVATCRSETVAYLIHEDVEGKRLSQVLS--GLSWERRRKIMKGIVEALRflHCR 795
Cdd:cd14023    24 KVFPLKHYQDKIRPYIQLPSHRNITGIVEVILGDTKAYVFFEKDFGDMHSYVRSckRLREEEAARLFKQIVSAVA--HCH 101
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1780598599 796 CSpAVVAGNLSPENIVIdvTDEPRLCLGLPGLLCM-------DA--------AYMAPETREHKEMTS--KSDIYGFGILL 858
Cdd:cd14023   102 QS-AIVLGDLKLRKFVF--SDEERTQLRLESLEDThimkgedDAlsdkhgcpAYVSPEILNTTGTYSgkSADVWSLGVML 178

                  ....*..
gi 1780598599 859 LHLLTGK 865
Cdd:cd14023   179 YTLLVGR 185
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH